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SUMMARY 
The stability study of drugs of forensic interest in human post-mortem 
blood is an important forensic study, because in some cases, a requirement for 
the laboratory to undertake a full drug screening is after a few months of 
storage due to a need for new evidence. Therefore, it is necessary and 
important to know if drugs are stable over a period of time under different 
conditions to enable a solid interpretation to be made from any results. 
Some studies have been published on the stability of drugs at different 
temperatures but none had covered the whole set of drugs that has been studied 
in this thesis. The periods of study that have been covered by other studies 
varied from a few days to a maximum of 70 weeks, but again not all drugs have 
been covered. 
The drugs studies in this thesis are two sets of drugs, benzodiazepines 
and tricyclic antidepressants, their stability being determined over twelve 
months and at three different temperatures 25,5 and -20°C. 
In this thesis, blood was 'spiked' with eight drugs, Diazepam, 
Temazepam, Triazolam, Desmethyldiazepam, Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine. The samples were stored with blanks at 
different temperatures for different storage times. Each month a number of 
samples were removed from storage and analysed to test the effect of storage 
time and temperature on drug concentration. 
Different solid phase and liquid-liquid extraction methods were tested 
for the determination of benzodiazepines. Liquid-liquid extraction methods for 
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the determination of Diazepam, Temazepam, desmethyldiazepam and 
Triazolam proved after study to be tedious and time-consuming. A method 
based on solid phase extraction was used to determine the four benzodiazepine 
drugs. The extraction method gave good recoveries and was highly efficient. 
The method of analysis used for the determination of stability of 
benzodiazepine drugs was the high performance liquid chromatography 
(HPLC) method. 
Tricyclic antidepressant drugs are the other drugs studied for their 
stability in blood. Different solid phase extraction methods were used for the 
determination of drugs in post-mortem blood but gave poor recoveries. The 
best method of extraction used was a liquid-liquid extraction method which 
yielded high recoveries and proved to be quick. The method of analysis used 
for the determination of tricyclic antidepressants for the purpose of stability of 
the study was gas chromatography (GC). 
At a recognised toxic level for each drug under study a reasonable 
amount of the drug was found to be detectable after one year at storage 
regardless of the storage temperature or media. The decrease rate of each drug 
concentration with time at the three storage conditions (25, 5 and -200 e) was 
obtained. 
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CHAPTER 1 
1.1 INTRODUCTION 
Depression is not only a common disorder but it is one that is readily 
treatable. Tricyclic antidepressants drugs playa major role in this treatment. 
They have been most beneficial in patients with endogenous depression. 
Besides being useful for treating depression they may be used for treating 
enuresis. 
The depression problem is universal. Approximately 2 - 15% of adults 
are believed to suffer depressive symptoms in any given year. The major 
complication of depression is that it is the tenth greatest cause of death for all 
ages. Because depression is a common problem in medical practice and as 
tricyclic antidepressants are the most often prescribed, this may lead to drug 
overdose in patients and may lead to death. 
Drug concentrations in blood and other biological fluids and tissues do 
not remain constant in a corpse in the interval between death and the collection 
of samples. Blood drug concentrations can change significantly during the post-
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mortem period. Since the early 1980s it has been clear that this problem 
particularly affects the antidepressants. 
One of the principal tasks in toxicological analysis is to detect whether a 
potentially harmful substance is present and to identify the substance(s) 
correctly, regardless of whether this is for clinical, forensic, environmental, 
workplace, drug abuse or doping control purposes. The analyst must be able to 
detect such compounds, identify them, differentiate between closely resembled 
ones and quantitate them within a reasonable amount of time. Establishing the 
presence of a harmful substance is not the only task in toxicological analysis. 
At the same time it is equally important to establish the absence of other 
toxicologically relevant substances within reasonable or significanllimits. 
The mam task of a toxicologist is to measure and interpret levels 
resulting from drug overdose. In this study on antidepressants, their stability in 
post-mortem blood over a period of time was investigated. 
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1.2 BENZODIAZEPINES 
When benzodiazepine was first synthesised in 1955, unlike other 
psycho tropics they did not attract much attention. It was only 5 years later that 
several clinical investigators reported their anxiolytic properties)1,2J The first 
report of the potential of benzodiazepines to cause a dependency carne in 
1961[3,4J only one year after the introduction of chlordiazepoxide. Since then 
there has been a steadily increasing number of papers concerned with 
benzodiazepines)5,6J 
In the UK benzodiazepine prescription figures produced by the 
Department of Health and Social Security (DHSS) indicate a fall from 30 million 
to 26 million between 1981 and 1985. Intravenous misuse of injected diazepines 
began in Britain in the mid 1980s. At first the drugs commonly used were 
Flurazepam and Diazepam but by the late 1980s, when the use of injected 
benzodiazepines had become widespread in several British cities, users were 
reported to be injecting mainly Temazepam from capsules.l7,81 
In 1989 the manufacturers replaced liquid filled Temazepam capsules 
with semi-solid gel filled capsules to prevent the drug from being injectedJ9,lOI 
These capsules, however, are also being injected and seem to lead to a greater 
rate of death in individual users. 
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Although benzodiazepine prescribing in the United Kingdom has been 
falling steadily, the number of prescriptions issued is still large. In England in 
1989, 21 million prescriptions for hypnotics, sedatives and tranquillisers were 
issued, the vast majority of these being benzodiazepines.fll ,12] 
Despite the fact that the benzodiazepines are extensively used, some 
doctors feel that benzodiazepines no longer have a place in clinical practice[13,14] 
Whereas others have gone the other way and suggest that benzodiazepine 
hypnotics should be available without a prescription as they are so much safer 
than the alternatives. It is therefore difficult for the average psychiatrist to 
know when to prescribe benzodiazepines. It is also difficult to know which 
benzodiazepines to prescribe because of conflicting accounts of their advantages 
and disadvantages. 
Nowadays, all practitioners prescribe benzodiazepines according to the 
circumstances. However, in anxiety occurring at a time of major stress, now 
normally diagnosed as acute stress, it may be appropriate to prescribe a 
benzodiazepine if the distress is severe and the prescription is likely to be short 
term. The other major use of benzodiazepines is in the treatment of alcohol 
withdrawal reactions. So, it was concluded that short treatment with 
benzodiazepines for a few weeks was safe from the risk of dependence,r15,16] 
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1.2.1 CHEMISTRY 
The basic structure for most benzodiazepines is shown in Figure 1. 
Figure 1: Basic Structure of Benzodiazepines 
1,4 benzodiazepine structure is only the fused ring portion. However, all 
the important central nervous system (CNS) depressant benzodiazepines 
contain a 5-aryl or cyclohexenyl substituent, so that the term benzodiazepines 
has corne to mean the 5-aryl-I, 4- benzodiazepine. 
The effects of the benzodiazepines result from the actions of these drugs 
on the CNS. The most prominent of these effects are sedation, hypnosis, 
decreased anxiety, muscle relaxation and anticonvulsant activity. It has minor 
cardiovascular effects except in severe intoxication. 
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1.2.1.1 Diazepam 
Diazepam is a benzodiazepine with anticonvulsant, anxiolytic, sedative, 
muscle relaxant and amnesiac properties. Diazepam is used in the management 
of severe disabling anxiety disorders, insomnia, convulsions, particularly status 
epilepticus and febrile convulsions, and in alcohol withdrawal. It is also used as 
a sedative for surgical and other procedures and for the relief of muscle spasm. 
Dependence may develop with regular use. Drowsiness, sedation and 
ataxia are the most frequent adverse effects. 
Diazepam is Chloro-l/3-dihydro-l-methyl-5-phenyl-2H-l,4-benzodiazepin~ 
I 
2-one. The structure is shown in Figure 2. 
C16H13C1N20 
CH3 I 
0 
N\O 
/N 
CI 
0 
Figure 2: Diazepam 
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Pharmacokinetics 
Diazepam is readily and completely absorbed from the gastro-intestinal 
tract, peak plasma concentration occurring within 0.5 - 2 hours of oral 
administration. 
Diazepam has a biphasic half-life with an initial distribution phase 
followed by a prolonged elimination phase of one or two days. 
Diazepam and desmethyldiazepam accumulate in the body on repeated 
administration and the proportion of desmethyldiazepam in the body increases 
on long term administration. 
Diazepam is extensively metabolised in the liver and in addition to 
desmethyldiazepam its active metabolites include Oxazepam and Temazepam. 
It is excreted in the urine, mainly in the form of its metabolites either free or in 
conjugated form. 
1.2.1.2 N -Desmethyldiazepam: 
N-Desmethyldiazepam is 7-Chloro-l,3-dihydro-5-phenyl-2H-l, 4-benzo 
diazepin -2-one. 
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Figure 3: N-Desmethyldiazepam 
Desmethyldiazepam is a long-acting benzodiazepine with the general 
properties of Diazepam. It is the principal active metabolite of several 
benzodiazepine drugs and has a half life of two to five days. It is used for the 
treatment of anxiety disorders and insomnia. 
1.2.1.3 Temazepam 
Temazepam is 7-Chloro-l,3-dihydro-3-hydroxy-l-methyl-5-phenyl-2H-
1,4-benzodiazepin-2-one. The structure is shown in Figure 4. 
Temazepam is a relatively short acting benzodiazepine. It is used as a 
hypnotic in the short term management of insomnia. It is also given for 
premedication before surgery. Temazepam may be given to children as a 
premedica tion. 
Pharmacokinetics 
I 
'-----
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Figure 4: Temazepam 
Temazepam is absorbed from the gastro-intestinal tract. It is 96% bound 
to plasma protein. Some studies show a half life of eight hours. Recent studies 
have shown a longer half-life of 15 hours. It is excreted in urine in the form of 
inactive glucuronide with small amounts of the desmethyl derivative, 
Oxazepam. 
1.2.1.4 Triazolam 
Triazolam is a short acting drug used in the management of insomnia. 
Dependence may develop after its regular use and its withdrawal symptoms are 
severe. Symptoms of anxiety, panic, paranoia and hallucinations have been 
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attributed to its continued use. As with all benzodiazepines, adverse effects 
may include drowsiness, sedation and ataxia. 
Triazolam is 8-Chloro-6-(2-Chlorophenyl)-1-methyl-4H-l,2,4-triazolo[4,3-a] 
[l,4]benzodiazepine. Its structure is shown in Figure 5. 
1-" 
~ .. -------____ --1 
Figure 5: Triazolam 
Pharmacokinetics 
Triazolam is rapidly absorbed from the gastrointestinal tract, peak 
plasma concentrations being achieved within two hours of administration by 
mouth. 
It is reported to be about 89% bound to plasma protein. Triazolam 
undergoes hydroxylation in the liver and is excreted in the urine in the form of 
its conjugated metabolites. 
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1.3 TRICYCLIC ANTIDEPRESSANTS 
1.3.1 INTRODUCTION 
Tricyclic antidepressant drugs were introduced in the 1950s and have 
been used clinically for more than 2 decades; these include Amitriptyline which 
is the most widely prescribed drug, Doxepin, Nortriptyline, Imipramine and 
Desipramine. 
Amitriptyline has been implicated in roughly half of all deaths attributed 
to tricyclic antidepressants both in the United Kingdom and in the United 
StatesJ17,18] Since the introduction of tricyclic antidepressants into clinical 
practice, antidepressant drugs have become the primary method of treating 
depressive ordersJ19,20) Tricyclic antidepressants are commonly encountered in 
autopsy toxicology. They probably present the most common life-threatening 
therapeutic drug ingestion world-wide. It is not surprising that they should be 
taken frequently in overdose which accounts for at least 5% of all positive 
toxicology screens.l21,22) Death from tricyclic overdose usually results from the 
well-documented cardiotoxicity of the compounds.l23,24) 
A study was done on fatal toxicity of antidepressant drugs. They 
calculated a fatal toxicity index for antidepressant drugs on sale during the 
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years 1975-84 in England, Wales and Scotland, which showed that the tricyclic 
drugs introduced before 1970 had a higher toxicity index than the other drugs. 
The toxicity of Amitriptyline, Dibenzepin, Desipramine and Dothiepin was 
significantly higher, while that of Clomipramine, Imipramine, Protriptyline and 
Trimipramine was lower. The monoamine oxidase inhibitors had intermediate 
toxicity and the antidepressants, introduced in 1978, had significantly lower 
toxicityJ19,25] 
Another study showed that twenty-nine coroners' cases were reported 
involving tricyclic antidepressants which included concentrations in the 
myocardium as well as in the liver and the blood.l26) 
Amitriptyline is the most frequently involved drug in tricyclic overdose, 
accounting for half or more of the poisonings. So, whenever Amitriptyline was 
found by this screening procedure the drug, and its pharmacologically active 
metabolite Nortriptyline, were quantified in the liver, myocardium and 
blood.l27) 
There are several groups of antidepressants: the tricyclic and related 
antidepressants; the monoamine oxidase inhibitors; and the serotonin re-
uptake inhibitors. 
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Antidepressant therapy has mainly been with tricyclic antidepressants 
(TCA). 
Both the dose and the duration of treatment are important when a 
patient is being treated for depression. An antidepressant must be given in and 
adequate dose to be effective. 
1.3.2 CHEMISTRY 
The 3-ring nucleus characteristic of these drugs has given them the name 
tricyclics. They closely resemble the phenothiazines chemically and, to a lesser 
extent pharmacologically. 
The general structure of antidepressants is shown in Figure 6. 
------------~ 
L _________ ----' 
Figure 6: General Structure of Tricyclic Antidepressants 
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1.3.2.1 Amitriptyline 
Death from Amitriptyline overdose is a significant problem in the 
Lothian and Borders region of Scotland, accounting for 21% of all fatal self-
ingested overdoses presenting to the Forensic Medicine Unit over a five year 
period. 
Twenty-four cases were reported in this study involving Amitriptyline as 
the major drug concernedJ28] 
In the University of California study of fatal self-ingested overdose 
involving Amitriptyline, the average age was found to be 44 years. Only five of 
the twenty-four cases in this series reached hospital before deathJ29] 
Current evidence does not show any clear clinical superiority of one 
antidepressant over another, though antidepressants have been found to differ 
in their side-effect profiles and in their toxicity. Amitriptyline poisoning 
remains a major clinical problem. However, it remains a widely prescribed 
antidepressant. 
Amitriptyline in general, typifies the group of drugs known as tricyclic 
antidepressants. It is used widely in melancholic depression and may also be 
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effective in some cases of atypical depression. It has marked anti muscarinic and 
sedative properties and prevents the re-uptake of Noradrenaline and Serotonin 
at nerve terminals. 
Amitriptyline is usually given as a hydrochloride by mouth or in divided 
dose of 75 mg initially, gradually increasing if necessary to 150 mg daily. 
Pharmacokinetics 
Amitriptyline is readily absorbed from the gastro-intestinal tract, peak 
plasma concentration occurring within a few hours of oral administration. 
Since Amitriptyline slows gastro-intestinal transit time, absorption can be 
delayed, particularly in overdosage. 
Amitriptyline undergoes extensive first-pass metabolism and is 
demethylated in the liver to its primary active metabolite, Nortriptyline. Other 
paths of metabolism of Amitriptyline include hydroxylation and N-oxidation; 
Nortriptyline follows similar paths. Amitriptyline is excreted in the urine, 
mostly in the form of its metabolites, either free or in conjugated form. 
Amitriptyline and Nortriptyline are widely distributed throughout the 
body and are extensively bound to plasma and tissue protein. Amitriptyline 
has been estimated to have an elimination half-life ranging from about 9 - 36 
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hours, which may be considerably extended in overdosage. Plasma 
concentrations of Amitriptyline and Nortriptyline vary widely between 
individuals and no simple correlation with therapeutic response has been 
established)30] 
Chemistry 
Amitriptyline is 3-(1O,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-
NN- dimethylpropylamine. The structure is shown in Figure 7. 
Figure 7: Amitriptyline 
1.3.2.2 Imipramine 
Imipramine is 3-(10, Il-dihydro-5H-dibenz[b,f]azepin-5-yl)-NN-
dimethyl- propylamine. The structure is shown in Figure 8. 
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" 
Figure 8: Imipramine 
The structure is similar to that of Amitriptyline. It has properties typical 
of the group of drugs known as tricyclic antidepressants. It is used widely to 
treat melancholic depression and may also be effective in some cases of atypical 
depression. 
This is given by mouth as the hydrochloride or the embonate. The usual 
dose is 25 mg three times daily initially, gradually increasing to 50 mg three 
times daily. 
Pharmacokinetics 
Imipramine is readily absorbed from the gastro-intestinal tract, and 
extensively demethylated by first-pass metabolism in the liver to its primary 
active metabolite Desipramine. 
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Paths of metabolism of both Imipramine and Desipramine include 
hydroxylation and N-oxidation. Imipramine is excreted in the urine, mainly in 
the form of its metabolites, either free or in conjugated form. Imipramine 
elimination half-life ranges between 9 - 28 hours. 
1.3.2.3 Nortriptyline 
Nortriptyline is a tricyclic antidepressant with actions similar to those of 
Amitriptyline and like other members of the tricyclic group it provides effective 
treatment for depression. In the treatment of depression it is given by mouth as 
a hydrochloride, starting with low dose and gradually inG"easing to the 
equivalent of 75 to 100 mg daily in divided dose. 
The structure is 3-(10, ll-dihyro-5H-dibenzo[a,d]cyclohepten-5-
ylidene) -N- methylpropylamine 
The structure is shown in Figure 9. 
Pharmacokinetics 
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Figure 9: Nortriptyline 
Nortriptyline is the principal active metabolite of Amitriptyline. It has 
been reported to have a longer plasma life than that of Amitriptyline. It is 
subject to extensive first-pass metabolism to lO-hydroxynortriptyline which is 
active. 
1.3.2.4 Chlorpromazine 
After more than thirty years of clinical use31) its metabolism is still of 
interest. Chlorpromazine and its metabolites play an important role in clinical 
responseJ32) Typical problems include instability, a tendency for adsorption 
loss and low analyte concentrations in clinical samples)33) Chlorpromazine is a 
phenothiazine used for the control of psychosis, including schizophrenia and 
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mania, and severely disturbed or agitated behaviour. It is also used for the 
relief of nausea and vomiting, pre-operative anxiety and intractable hiccup. 
Chlorpromazine is 3-(2-Chlorophenothiazin-10-yl)-NN-dimethylpropyl-
amine. Its structure is shown in Figure 10. 
r~~"-­
! 
Figure 10: Chlorpromazine 
Chlorpromazine and other phenothiazines produce in general a lesser 
degree of central depression than barbiturates or benzodiazepines. 
Phenothiazines have antimuscarinic properties, hypersensitivity reactions and 
various haematological disorders may occur. 
The effect of Chlorpromazine on blood was provided in data from the 
UK Committee on Safety of Medicines. It provided data on reports it had 
received between 1963 and 1993 on agranulocytosis and neutropenia.l32] The 
study showed that the most frequently implicated phenothiazines were 
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Chlorpromazine with 51 reports of agranulocytosis (26 fatal) and 12 of 
neutropenia (2 fatal). 
Pharmacokinetics 
Chlorpromazine is readily absorbed from the gastro-intestinal tract; 
peak plasma concentration was attained 2 to 4 hours after ingestion. It is subject 
to considerable first-pass metabolism in the gut wall and is also extensively 
metabolised in the liver and is excreted in the urine and bile in the form of 
numerous active and inactive metabolites. 
The paths of metabolism of Chlorpromazine include hydroxylation and 
conjugation with glucuronic acid, N-oxidation, oxidation of a sulphur atom and 
dealkylation. 
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CHAPTER 2 
2.1 STABILITY OF DRUGS 
The stability of drugs in biological specimens is of interest to forensic 
toxicology laboratories. The validity of toxicological test results for a given 
specimen may be disputed in the medicolegal community. This dispute may 
involve challenge by a defence attorney to have a specimen reanalysed by 
another laboratory. In this case, knowledge of the stability of a drug is also of 
importance for situations in which the time period between an initial 
presumptive screen and the subsequent confirmation is significant. Several 
studies on drug stability have been reported. A study was reported on post-
mortem stability of benzodiazepines in blood and tissues; Diazepam was found 
to be very stable over a five month period when stored at room or refrigerated 
temperatures while decreases in Nordiazepam concentration were observed at 
both temperatures, with the greater and more rapid decreases in blood at room 
temperature. The presence of Chlordiazepoxide and Norchlordiazepoxide was 
not detected after 18 days from the time of addition to the blood. Diazepam 
showed no significant change in concentration after three months of storage in 
both liver and brain. Nordiazepam at both temperatures after two months of 
storage showed a decrease, with the greatest decrease occurring in the liver 
stored at room temperature.l341 Another study reported the stability of drugs 
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and poisons in putrefying human liver tissues, where Chlorpromazine showed 
a total loss from liver tissue containing 100 pg/ g of drug when stored in closed 
vessels at 15°C and 29°C over a period of 53 days. However, the concurrent 
storage of tissues containing Amitriptyline and Imipramine resulted in no loss 
of these drugs from the tissues.l35) Formalin blood solutions were monitored 
daily for thirty days. The formalin blood solution losses were found for 
Diazepam and Phenytoin over the 30-day period of at least 41% and 33%, 
respecti vel y. The study revealed that the drugs examined at toxic 
concentrations can be detected, with variable recoveries, for up to 30 days after 
fixation with formalin.l36) Stability of drugs of abuse in urine samples stored at -
20°C was determined for Amphetamine, Methamphetamine, Morphine, 
Codeine, Cocaine, Benzoylecognine and Phencyclidine in 236 physiological 
urine samples for a period of twelve months. The average change in the 
concentrations of these drugs was not extensive except for an average change of 
-37% in cocaine concentrationsP7) The storage effect at room, refrigerator and 
freezer temperatures, on the stability of Morphine and Codeine in urine was 
reported; total Morphine, total Codeine, free Morphine and free Codeine in 
samples were analysed at thirty day intervals for an eleven month period. Total 
Morphine and Codeine concentration decrease was observed for all specimens 
in all storage conditions. For samples stored in the refrigerator and freezer, 
decrease was in the range from 10 - 40%. For samples stored at room 
temperature, the decrease was larger for total Morphine, total Codeine. Total 
Morphine concentrations show a decrease pattern similar to that observed for 
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the freezer and refrigerator storage conditionsJ38] A five year stability of 
common illicit drugs in blood was reported. The drugs of interest in this study 
were cocaine and Benzoylecgonine, Methamphetamine and amphetamine, 
nonconjugated Morphine and Codeine, and phencyclidine (PCP). The 
specimens were collected in Vacutainer tubes containing sodium fluoride and 
potassium oxalate. The tubes were stored at room temperature. Cocaine and 
Benzoylecognine have poor stability. Methamphetamine and PCP were both 
fairly stable and had a high probability of confirmation upon reanalysis. While 
Morphine initially decreased then increased at the 3 year interval, and finally 
decreased at 7 and 5 year intervalsJ39] 
The stability of Morphine and Buprenorphine were also reported in 
whole blood. Both drugs were found to be very stable for up to six months 
under the storage conditions (4°C, 25°C, -20°C). At least 85% of Morphine and 
77% of Buprenorphine were recovered and not less than 70% was still detectable 
after one year of storage regardless of the temperature, especially when blood 
samples were stored in silanized glass vesselsJ40] Another stability study was 
done on a wide range of drugs including Temazepam, where Temazepam 
stability was studied at 5°C, 25°(, -20°C, in aqueous and blood samples for a 
period of one year. Blood Temazepam samples showed a significant decrease 
on their concentration after one month of storage with a recovery of 92% from 
the day zero. The decline in Temazepam concentration continued and 80% of 
the drug was recovered after six and a half months. The lowest recovery 
- 27 -
reached 50% after one year of storage. While Temazepam aqueous samples 
showed no significant change in concentration for day zero up to two and a half 
months. A significant decrease in concentration was noticed after six months of 
storage with a recovery of 88% from day zero. 50% of the drug was still 
detected after one year of storage in aqueous samples.l41J 
2.1.1 BENZODIAZEPINES 
2.1.1.1 Introduction 
Although many techniques have been developed for the extraction of 
benzodiazepines and their metabolites from body fluids, difficulties remain in 
the detection and quantification of these compounds in the blood samples 
routinely encountered in forensic casework.l42J Such samples are varyingly and 
usually extensively haemolysed and are often putrified. Large amounts of 
solidified and coagulated materials may be present and there may be serious 
contamination by plasticizers and by components of the elastomers e.g. in 
rubber septa, with which the samples may come into contact during their 
collection and storage. The amounts of blood available for examination may be 
small and further restricted by the requirements of other analyses. Sometimes 
the concentration of benzodiazepines might be very low. Therefore, a good 
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extraction technique with high recoveries is needed to detect benzodiazepines 
and metabolites in biological material presented for toxicological analysis. 
Several extraction techniques based on either liquid extraction or solid 
phase extraction have been developed for the determination of benzodiazepines 
in urine, plasma and whole blood. 
2.1.1.2 Solid Phase Extraction 
Solid phase extraction techniques have gained popularity for many 
biochemical, clinical, industrial and environmental applications because of their 
efficiency and ability to provide a clean extract in a single step. 
High recoveries and selective extraction are especially important in drug 
screening in forensic toxicology, where specimens are complex and sometimes 
contain drugs at low concentrations. 
The principle of liquid/solid phase extraction is closely related to 
conventional liquid-liquid extraction. Described in 1976[43] it involves the 
absorption of the aqueous phase onto diatomaceous earth, a porous material 
which acts as a support for the aqueous phase. This provides a large surface 
area for partition into an eluting solvent, which flows through the immobilised 
specimen under gravity, eluting the analytes of interest. The next major 
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development was the partition chromatography where a polar solvent (water) 
stationary phase was held by adsorbing it on silica gel and moving a second 
solvent (chloroform modified with ethanol) through the column as the mobile 
phase to isolate and separate acetyl derivatives of aminoacids. In this system, 
chromatographic separation was achieved, not by adsorption of the compounds 
onto a solid phase but by partitioning of the solute between two liquid phases 
according to distribution isothermJ44] 
Over the past decade, solid phase extraction (SPE) has emerged as a 
powerful technique for the pre-treatment of biological samples for clinical and 
toxicological analysisJ43-47] 
Solid phase extraction has given more reproducible results since it is 
based on specific molecular interactions. The easy use of the column allows a 
large number of samples to be processed and the procedure can be 
automated.[48] 
The majority of publications have been geared towards the extraction of 
the individual drug or groups of related drugs, for example, extraction of 
Temazepam on its own or extraction of weak and strong basic drugs using the 
same extraction columnJ49-53] 
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The use of solid phase extraction columns as an alternative to liquid-
liquid extraction for the isolation of drugs from biological samples has gained 
popularity over recent years because of the reported excellent recoveries and 
ease of use.l54-57] 
The majority of reported solid phase methods for the extraction of 
benzodiazepine drugs from body fluids involve the use of reversed bonded 
phase columns (C2, Cs and C1S)[57-621 and since benzodiazepines are considered 
as weak basic compounds and are better extracted on non-polar sorbents, other 
methods were reported where ion exchange lion pairing extraction and mixed 
mode extraction methods have been used and were reported to be highly 
efficient in the recovery of various drugs from biological fluids[53,61,621. One of 
the extraction procedures reported was for the quantitation of diazepam and N-
desmethyldiazepam from blood using an inexpensive source of diatomaceous 
earth (Celite 560) which gave good recoveries.l60] Another method was reported 
where non-ionic Amberlite XAD-2 (polymeric sorbent consisting of styrene-
divenylbenzene and polyacrylate structure) was used for confirming the 
presence of benzodiazepines in urine by hydrolysing benzodiazepines to 
benzophenones in an acid medium. It was described as a simple and reliable 
method but has no differences in hydrolysis efficiency among benzodiazepines 
which preclude the use of a single calibration graph.l611 C2-AAP cartridges 
were used for screening of benzodiazepines in biological samples. The 
extraction time was five minutes and recovery ranged from 92 - 104% and was 
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independent of concentration.l59] A rapid method of isolation of 
benzodiazepines from human samples was with Sep-Pak CIS cartridges where 
the drugs were dissolved in alkaline samples, directly applied to the cartridges 
and eluted with hexane: isopropanol (9 : 1). The recoveries were excellent for 
all drugs in urine samples but were lower in plasma samples.lsO] An extraction 
method for the determination of Triazolam and its metabolites in human urine 
has been reported where a Sep-Pak CIS cartridge was used and further purified 
by Sep-Pak Silica cartridge. The reported recoveries of Triazolam, 1-
hydroxymethyltriazolam and 4-hydroxytriazolam were 88, 75 and 75%.149) 
An automated sample preparation module (ASPEC) was reported for the 
determination of four benzodiazepines in plasma. Extraction was carried out 
on disposable CI8 cartridges and involved several washing steps. The drugs 
were desorbed with ethylacetate. The limits of detection in plasma were 0.5 - 2 
ng/ml.l61 ) Another automated on-line solid phase extraction method was 
reported where the extraction was performed on LC-18 cartridges and eluted 
with ethylacetate. The method gave satisfactory recoveries when using a 
washing mixture of water: methanol (95 : 5 v Iv) prior to elution.l62] 
The mixed mode solid phase extraction reported was Bond Elut Certify 
columns where the columns were used for isolation of a broad range of drugs 
including benzodiazepines and where urine or serum samples were mixed with 
phosphate buffer before applying to the pre-conditioned column. The drugs 
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were eluted with methanol: 10% ammonia (5: 1). The reported recoveries for 
drugs ranged between 71 - 99% at a concentration of 10 J.U11ol/LJ63] The other 
Bond Elut Certify extraction reported was for benzodiazepines in urine samples 
where the samples were incubated with p-glucuronidase enzyme to convert 
benzodiazepines to aminobenzophenones before applying them to the sorbents. 
The recoveries were reported as excellent recoveries.[64] 
2.1.1.3 Liquid-Liquid Extraction 
Several liquid-liquid extraction methods have been developed for the 
quantification of benzodiazepines from liver, serum, plasma and whole blood. 
A single step liquid-liquid extraction method was used to extract 
benzodiazepines from liver where l-chlorobutane was used for the extraction 
and the assay allowed detection of 5 to 20 pg of drug/kg of tissueJ65] Another 
method of liquid-liquid extraction was used to extract twelve benzodiazepines 
from serum. The procedure required only 1rnl of serum. The samples were 
extracted using potassium carbonate and chloroform and it gave recoveries of 
more than 95%)66) 
An extraction method that had definite forensic application to post-
mortem blood, where only one rnillilitre of blood sample is required and n-
butylchloride is used for extraction, the sensitivity of the procedure was 
Diazepam (1-5 pg/ dL) and NorDiazepam (5-10 pg/ dL)J67) 
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A method was reported which used a one step extraction of whole blood. 
It required 1.0 ml sample, 1.0 ml buffer, a few hundred III of solvent and less 
than 2 min. of technologist time and had recoveries of 80 - 82%,168] A liquid-
liquid extraction method was reported for benzodiazepines where the drugs 
were extracted from 1ml of buffered blood with n-hexane-dichloromethane 
(70: 30) at pH9 and where no derivatization step was needed, prior to gas 
chromatography analysis. The recoveries were between 70 - 97%,169] Ether 
extraction of sixteen benzodiazepines in blood samples treated with aqueous 
ammonia has been reported and that method yielded recoveries of 70 -75%,170] 
A sensitive method for the determination of Temazepam in plasma was 
reported where a liquid-liquid extraction method was used, with 
dichloromethane : pentane (1 : 1) as the extracting solvent. The detection limit 
was 3.5 ng/ml,!71] Toxi-tube A was reported to be used for liquid-liquid 
extraction of 600-compounds including several benzodiazepine drugs of 
interest, where 1 ml of urine or whole blood was mixed with distilled water 
after extraction and centrifugation. The sample was reconstituted with 
acetonitrile: water (50: 50 v Iv) before analysis on the HPLC system. Clear 
extracts were reported and this gave low interference chromatographic analysis 
which enhanced the drug detection.l72] A method was reported where parent 
benzodiazepines can be identified by converting them to aminobenzophenone 
using l1-glucuronidase enzyme. The extracting solvent used was a mixture of 
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isobutyl alcohol: methyl-chloride (1 : 9). The limit of detection was reported as 
200 ng/ml.!641 
2.1.2 TRICYCLIC ANTIDEPRESSANTS 
2.1.2.1 Introduction 
Antidepressant drugs are highly protein bound and the therapeutic 
concentrations of the free fraction of these drugs are quite lowJ731 Routine 
determination of the free fraction of antidepressant drugs is an analytical 
challenge. 
Various extraction procedures are available, varying from triple liquid-
liquid extractions to solid phase extractions. Colour tests, such as Forrest's 
reagent, are also used by some laboratories to detect the presence of some of the 
tricyclics in toxicological specimens.f741 
2.1.2.2 Liquid-Liquid Extraction 
Until recently, extraction of antidepressants from biological samples with 
water immiscible organic solvents has been the most popular technique. A 
number of different approaches have been used. 
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Liquid-liquid extraction equipment is mainly glass culture tubes with 
PTFE-lined screw caps with different dimensions. Some procedures require 
silanisation of the tubes to minimise adsorption of drugs onto the glass. 
Different methods have been used to silanise the tube, for example, with 
dichloromethylsilane. In some cases it was soaked overnight)75] while in others 
for as little as 5 minutes,l76] Another approach to avoid adsorption of drugs, is 
to extract the drugs in plastic polypropylene tubes. There is a wide range of 
time suggested for vortex mixing the sample with the organic solvent ranging 
from 30[77] to 15 minutes,l78] Mixing, particularly high speed vortex mixing of 
plasma with organic solvents, can lead to the formation of an emulsion. Use of 
rotary mixers at slow speed allows simultaneous mixing of a large number of 
samples uniformly with reduced emulsion formation. 
N-hexane is an example of one of the solvents used for the extraction of 
antidepressant drugs where the recoveries reported were 92 - 110%.179,80) 
The liquid-liquid extraction procedure, to extract tricyclic 
antidepressants from liver, was published where chloroform was the solvent 
used for extraction and where it gave good recoveries. The purpose of this 
study was to further examine the experiences with liver TeA concentrations as 
causes of death.l81] N-chlorobutane was used as the extraction solvent in 
another study where a 2 ml blood sample was used. After performing the 
extraction and evaporation steps, the drugs were reconstituted with 50% hexane 
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in ethanol. The study gave good recoveries for the Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine as follows: 
69.2%,59.8%,79.8% and 56.9%, respectivelyJS2,S3) 
Amitriptyline and Nortriptyline were liquid-liquid extracted from 
plasma by multi centrifugation steps and one washing step with normal saline, 
which gave high recoveries for plasma Amitriptyline and low recoveries for 
plasma Nortriptyline due to the difference in distribution in blood 
compartment. Amitriptyline is found predominantly in plasma whereas 
Nortriptyline is more concentrated into the cellular fraction.l841 
N-butylacetate, in another study, was the solvent of choice for the 
extraction of tricyclic antidepressants from blood due to its lack of volatility and 
its polarity which is essential in a single-step extraction without evaporation, 
and gave good recoveries at the same time.l681 
Another simple and rapid method was reported. I ml of plasma was 
used where it was extracted with Butan-I-ol in hexane. The recoveries of 
Amitriptyline and Nortriptyline were 90 and 87%, respectively.l851 
A simultaneous method of extraction was reported for Imipramine, 
Desipramine and their 2- and 10-hydroxy metabolites. The drugs were 
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extracted from plasma or urine at pH 8.5 with diethylether and back extracted 
in O.lM orthophosphoric acid. The recovery of the compound ranged from 
78.6% for Imipramine to 94.3% for 2-hydroxydesipramine.!86) 
A forensic determination of eleven cyclic antidepressants using liquid-
liquid extraction was reported. The samples were extracted by 20% Na2C03, 
water and n-hexane-isoamylalcohol (98.5 : 1.5 v Iv). The relative recoveries in 
human serum ranged from 94-103% for all drugs.!87) 
2.1.2.3 Solid Phase Extraction 
In the last few years a number of solid phase extraction procedures have 
been described for the determination of antidepressants. 
Bonded phase silica, e.g. Octadecyl, octyl, phenyl and cyanopropyl have 
been the commonly used supports for the extraction of antidepressant drugs. 
Cation-exchange and mixed phase bonded silica are also being used for the 
antidepressants. 
In some procedures, cartridges packed with diatomaceous earth, e.g. 
ClinElut or Extrelut, have been used for the extraction of antidepressants.!88) 
Other procedures used Sep-Pak ClS,l89,90) Baker Bond ClS[91), Bio-Rad C18[92) 
, 
Bond Elut CN(93), Baker Bond CN[55) and Bond Elut C2 Extraction Cartridges. (94) 
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All of these solid phase extraction procedures claim to give clean extracts with 
excellent recoveries of the desired drugs. 
Antidepressant drugs are high protein-bound. Recovery of these drugs 
by solid phase extraction can be variable and low due to incomplete liberation 
of drugs bound with proteins. The simplest approach to minimise the effect of 
protein binding is to pass the sample through the sorbent at a slow rate.l911 In 
another study, the sample was diluted with an equal volume of water)551 and in 
another it was diluted with an equal volume of O.lM ammonium hydroxide.l921 
A study described the addition of methanol to precipitate proteins. The 
resultant supernatant was applied to the extraction cartridge.l90] 
Another study used a method to precipitate proteins by adding two 
volume of acetonitrile and then processing the supernatant by solid phase 
extraction which recovered Imipramine with a yield of 97%,[551 
Several solid phase extraction methods has been described for the 
extraction of antidepressants from plasma, whole blood and urine samples. 
Some studies were done on the extraction of tricyclic antidepressants 
from urine. One was carried out on 1 ml Bond Elut strong cation exchange 
(SeX) columns. These contain 40 llm silica particles with an alkyl bonded 
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benzene sulfonyl propyl moiety which give the sorbent the ability to participate 
in both cation exchange and nonpolar interactions.l53) 
Some other methods were reported for the extraction of tricyclic 
antidepressant from serum. One was done using two solid phase cartridges of a 
graphitized carbon black (Carbopack B) cartridge and a silica based strong acid 
exchanger. After applying serum samples on Carbopack cartridge, the tricyclics 
were removed from the Carbopack surface and selectively readsorbed onto the 
cation exchange surface by passing methylene chloride: methanol (60: 40 v Iv) 
through the two cartridges. The drugs were eluted from the cation exchange 
surface with acetonitrile: methanol: water (72: 18: 10 v Iv Iv). The recoveries 
exceeded 90%.195) Another on-line solid phase extraction method was reported. 
It was performed on a bonded phase CN column to extract Amitriptyline 
and Nortriptyline from serum. The relative standard deviation ranged from 
2.8 - 8.0% for concentrations of 200-40 ng/ml.l96) 
Other studies were reported for the extraction of tricyclic antidepressants 
from plasma. One was performed on Cyano bonded silica cartridges. The 
samples were acidified then applied to the preconditioned column. The drugs 
were eluted with acetonitrile: triethylamine (100: 0.15 v Iv). The recoveries 
ranged between 93 -102%.197) Another was described as a rapid and reliable 
procedure for the simultaneous determination of Chlorpromazine and thirteen 
of its common metabolites in human plasma using Cs bonded phase columns.l98] 
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Some reported studies show the extraction of tricyclic antidepressant 
from blood. One was done on Cg Empore solid phase extraction membrane 
(SPE14) where drugs were eluted from the column with a mixture of water-
acetonitrile-aceticacid-n-butylamine (600: 400: 2.5 : 1.5 v Iv Iv), which was the 
mobile phase, thereby avoiding evaporation steps that can affect drug stability. 
Recovery for all drugs exceeded 90%,I99J Another method was used where 
aqueous blood sample (blood diluted with water) was centrifuged, then 
supernatant was applied to a carbon sorbent (Supelclean - ENVIcarb) then 
eluted with TFA methanol (15% trifluroacetic acid) followed by xylene-
methanol. The eluent was then applied to the second sorbent, a cation exchange 
sorbent (Bond Elut PRS cartridges), and eluted with 2% ammonia-methanol-
ethylacetate. The absolute recoveries reported were 96.7%, 100% and 88.1% for 
Nortriptyline, Imipramine and Chlorpromazine, respectivelyJlOO] A method 
was described for the extraction of tricyclic antidepressant from plasma, whole 
blood and urine on Bond Elut Certify Columns. According to this study the 
tricyclic antidepressants were detected at concentration of 100 - 200 ng/mlJlOl] 
While the recoveries were described as reproducible in another Bond Elut 
Certify solid phase extraction method, the blood was pretreated by mixing it 
with phosphate buffer (pH 6.0) then the supernatant was applied to the 
preconditioned column and, finally, eluted with ethylacetate containing 2% 
(v Iv) of 25% ammonia solution.l102J 
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For the extraction of a large number of samples, manual solid phase 
extraction is tedious and somewhat slow. A number of manufacturers have 
marketed instruments which allow automatic performance of some or all of the 
steps of the solid phase extraction procedure using different extraction 
sorbents.f103,104j 
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2.2 DRUG ANALYSIS 
2.2.1 BENZODIAZEPINES 
2.2.1.1 
Because the world-wide market for benzodiazepines anxiolytics and 
hypnotics is extremely large, benzodiazepines continue to be developed, 
evaluated and introduced for clinical use. Demonstrating the presence or 
absence of a benzodiazepine in a biological sample can have important legal 
and medical consequences. Identification of a benzodiazepine in an impaired 
driver's blood can help corroborate an arresting officer's statement, while, in a 
hospital setting, detection of benzodiazepine is necessary to ensure compliance 
with prescription orders. The assay methods used to determine their 
concentrations are important to evaluate their pharmacokinetics, bioavailability 
and clinical pharmacology, and to detect and identify them in toxicological and 
forensic samples. The assays methods include mainly gas chromatography, 
gas chromatography-mass spectrometry,[105,1061 radio-immunoassay and radio-
receptor assay.l1071 Colorimetric and spectroscopic techniquesl1081 lack 
sensitivity and specificity. 
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2.2.1.2 Thin Layer Chromatography (TLC) 
Thin layer chromatography RF x 100 values of parent benzodiazepines 
have been measured on three TLC systemsJI091 Two dimensional TLC 
identification of twelve l,4-benzodiazepines or their hydrolysis products (the 
corresponding aminobenzophenones) has been reported.l l101 
Methods for the rapid, reliable and sensitive detection and identification 
of eighteen 1,4-benzodiazepines drugs (including Chlordiazepoxide, Diazepam, 
Nitrazepam, Temazepam, Prazepam and others), have been presented.l1ll1 The 
methods were based on the hydrolysis of the l,4-benzodiazepines in acidic 
media to the corresponding aminobenzophenones and their thin layer 
chromatography separation using two mobile phases and detection with 
Bratton-Marshall reagent directly or after photochemical dealkylation. A 
combination of TLC and other chromatographic systems were reported. A 
method of drugs screening was reported where solid phase extraction and 
combined TLC and GC/MS were used to identify different drugs including 
benzodiazepines.[l121 
2.2.1.3 High Performance Liquid Chromatography (HPLC) 
High performance liquid chromatographic methods have been described 
for the analysis of benzodiazepines. These techniques have offered greater 
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specificity and sensitivity over immunological procedures and colorimetric and 
spectrophotometric methods, are also more suitable than CG for thermally 
labile compounds, and do not require derivatization or hydrolysis prior to 
analysis. 
Retention data using both silica and ODS-silica in HPLC have been 
given. HPLC retention characteristics of 21 benzodiazepines and some of their 
metabolites have been examined on both silica and ODS-silica packing 
materialsJ1l31 Four HPLC systems have been considered and retention data 
were presented for the compounds on these four HPLC systems. The 
correlation of retention data on the system was considered with reference to the 
problem of identifying unknown benzodiazepines. An HPLC support was 
prepared, based on silica beads coated with ~-cyclodextrin containing polymer, 
which allows the elution of solutes in order of their affinity to ~­
cyclodextrin.ll141 
A complete reversed-phase HPLC separation of benzodiazepines was 
achieved in 50 minutes with detection limits of less than 3 ng/ml in urine and 
5 ng/ml in other biological fluids when using a suitable gradient elution.l1l5) 
A molecular rearrangement of aminobenzophenones (hydrolysis 
products of l,4-benzodiazepines) to 9 acridones has been studied. Its chemical 
structure is shown in Figure 1 U 1161 
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Figure 11: 9-Acridones 
The compounds synthesised were analysed by HPLC with fluorescence 
detection, because of their high luminescence. The method can detect sixteen 
benzodiazepines simultaneously, but ten different arninobenzophenones are 
formed from the sixteen benzodiazepines considered. It is reliable for the 
analysis of these compounds in biological samples at therapeutic 
concentra tions.l l16) The separation, isolation and identification of 1,4-
benzodiazepine glucuronide (oxazepam, cinolazapam) from biological fluids by 
reversed-phase HPLC has been reported.l1l7) A number of HPLC methods have 
been described for the determination of Diazepam and its major metabolites in 
urine samples.l1l8) Other methods are available for their analysis in blood, 
serum and saliva samples by HPLCJ1l9) HPLC methods for the separation of 
benzodiazepines in plasma has been studied.l1201 Another method for the 
analysis of benzodiazepines in serum where a 100 x 2.1 mm I.D, 3 pm particle 
size Cs analytical column was used and the assay for major benzodiazepines 
was linear in the range of 50-2000 ng/ml. Regression analysis showed a 
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correlation coefficient of greater than 0.999)52] Separation of parent 
benzodiazepines and their major metabolites by reverse-phase ion-pair 
chromatography from biological specimens was studied, where the separation 
used a reversed-phase Cs column with a variable ultraviolet (UV) 
detector.[l21,123] A combined GLC-ECD and HPLC procedure reported in 1978 
for the analysis of the most commonly encountered benzodiazepine drugs has 
been applied to both plasma and post-mortem blood samples)122] Two HPLC 
systems, one based on silica and the other on a reversed-phase ODS-silica, were 
used to detect the efficiency and cleanliness of ether extraction for 
benzodiazepines in blood samples treated with aqueous ammonia)701 HPLC 
determination of Triazolam and its metabolites in human urine where the 
extract was chromatographed on a reversed-phase column with a UV detection 
at 220 nm was used. The overall recovery for Triazolam was 88%, and its 
detection limit was 5 ng/ml, using a 10 III specimenJ123] Another reported 
method used HPLC with electrochemical reductive detection. This enabled the 
determination of benzodiazepines and their metabolites in small samples of 
degraded and contaminated blood, which are typical in forensic science work, 
and the recovery values were 75 - 95%J124] A rapid isolation of benzodiazepines 
with Sep-Pak C18 cartridges from urine samples were reported. The recoveries 
recording to the study were excellent.l58,721 Simultaneous determination of 
twelve benzodiazepines in human serum was performed on a C1S reversed-
phase column (ODS-C1S)' The method was sensitive for the twelve drugs.!661 
Six hundred compounds including benzodiazepines were analysed with a 
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multi-step gradient on a symmetry Cs 5 11m column, operated at 30°C. The 
method gave less peak tailing, lower identification limits and more stable 
retention timesJ72) HPLC with photodiode-array detection for basic drugs in 
serum was reported using Hypersil 5 11m (particle size) octadecylsilane C18 
columnJ63) 
2.2.1.4 Gas Chromatography (GC) 
The analysis of benzodiazepines and their metabolites by gas 
chromatography (GC) has been the subject of many investigations. The 
analytical problem is compounded as these drugs undergo extensive 
biotransformation to products that are widely distributed and are present in 
low concentrations after therapeutic doses. 
Several methods have been reported for the analysis of benzodiazepines 
in biological samples. A general method for the trace analysis of 
benzodiazepines and their major metabolites in O.2ml blood samples has been 
described. The method involves solvent extraction of blood with toluene, and 
isolation of the analyte using deactivated Amberlite XAD-7 porous polymer 
beads. The subsequent analysis of the cleaned up extracts used capillary 
column GC with ECD. The clean-up technique eliminates lipids and other 
interfering material, enabling routine analysis of blood extracts to be carried out 
with no significant deterioration in column or detector performance over a 
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period of many months. The use of fused-silica capillary columns coated with 
5E-52 and the correct choice of chromatographic conditions permits 
benzodiazepines of widely differing volatilities and polarities to be analysed 
without derivative formation. Data for 26 benzodiazepines and metabolites are 
presented,l1261 
Another method for the analysis of benzodiazepines in post-mortem 
blood has been reported. The method reported used optimum characteristics 
from published methodology using only one millilitre of blood sample. The 
data obtained for qualitative and quantitative analysis is presented to show the 
scope and reliability of the method. The method provides an effective screen 
for the common benzodiazepines in a total of 30 minutes from extraction to the 
Gc. The approximate sensitivity of the procedure was 1 - 5 llg/ dl for Diazepam 
and Clonazepam and 5 -10 llg/ dl for Nor Diazepam.l1271 
A solvent modified solid phase micro-extraction for the determination of 
Diazepam in human plasma sample by capillary gas chromatography was 
reported. The method was shown to be reproducible with a detection limit of 
0.10 nmol/ml in human plasma,l1281 An automated on-line solid phase 
extraction using gas chromatography with nitrogen-phosphorous detection for 
the determination of benzodiazepines in human plasma was reported in 1997,[621 
With a sample volume of 1 ml the procedure showed good linearity and 
repeatability in the range 5 - 50 ng/ml. The limits of detection in plasma were 
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0.5 - 2 ng/ ml. This study showed that capillary gas chromatography (GC) is 
the separation method of choice for the trace analysis of complex mixtures 
because of its good separation efficiency and the availability of a wide range of 
sensitive and selective detectors. 
A rapid twin-column GC method for the simultaneous screening and 
determination of commonly prescribed benzodiazepines from plasma and 
whole blood is presentedJ691 Identical fused silica SE-S4 columns were 
commited to a common split-splitless injector. Nitrogen-phosphorous and 
electron capture detectors were used to monitor the effect for such columns. By 
combining these specific and sens~tive detectors considerable and accurate 
chromatographic information was obtained in a single run. The drugs were 
extracted from 1 rnl of buffered plasma or blood with n-hexane-
dichloromethane (10: 20) and analysed without derivatization. The method 
was sensitive enough to permit reliable quantification of plasma Diazepam, 
Nordiazepam, Temazepam and Triazolam within twelve minutes. 
Toxicological analysis of whole blood samples by means of GC with nitrogen-
phosphorous detection was studied for a wide range of drugs including 
benzodiazepinesJ1021 An automated sample preparation module was interfaced 
with a capillary gas chromatograph (GC) by means of a loop-type interface. The 
system was optimised for the determination of four benzodiazepines in plasma. 
Only 110 pI aliquot of the eluate was injected into the GC via the loop-type 
interface using fully concurrent solvent evaporation conditions. Detection was 
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by means of a nitrogen phosphorous detector (NPD). The procedure was 
reported to show good linearity and repeatability in the range 5 - 50 ng/ml and 
limits of detection in plasma were 0.5 - 2 ng/mU62) Determination of Triazolam 
in a drug tablet by thermally desorping the drug and then applying it to the GC 
system with flame ionisation detection (FID), Triazolam in the tablet sample 
(about 3 J.lg/mg) could be determined using the calibration curveJ129) 
2.2.1.5 Gas Chromatography-Mass Spectrometry (GC-MS) 
A GC-MS method for identification of parent Benzodiazepines from 
urinary extracts treated with pglucuronidase was reported, excellent 
quantitation was achieved within eight minutes run time and the cutoff 
concentration for a positive result was set at 200ng/ml.!64) Another method for 
the identification and differentiation of 30 benzodiazepines and their 
metabolites in urine after acid hydrolysis and acetylation has been 
publishedJ130) The acetylated extract was analysed by computerised GC-MS. 
An on-line computer allowed rapid data processing of ions using ion 
chromatography with mass to charge ratio of its ions as follows: 
205,211,230,241,249,312 and 333. 
The identity of positive signals to the reconstructed ion chromatograph 
was confirmed by a comparison of the stored full mass spectra with reference 
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spectra. The ion chromatogram relevance mass spectra on GC retention indices 
on OV -101 are documented. 
A specific and sensitive assay has been developed to quantitate 
Triazolam in post-mortem blood using 2H6.Triazolam as an internal standard. 
Triazolam was isolated from whole blood by adsorption on an Amberlite XAD-
2 resin and subsequentlty eluted with an organic solvent. The extract was 
analysed by GC-MS using selected ion monitoring (GC/MS/SIM) in the 
negative chemical ionisation mode (CI-),[131) 
A simple confirmation procedure for the presence of benzodiazepines in 
previously screened positive urine samples was reported where samples are 
manually hydrolysed to the corresponding benzophenones in an acid medium. 
The hydrolysis products are aspirated into a photometric flow system for 
screening; positive samples are then confirmed and benzodiazepines identified 
by using a different flow system that conditions the analytes for GC separation 
and unequivocal mass spectrometric confirmation. Detection limits for 
benzodiazepines in the nanogram/millilitre range are achieved by using 0.5 ml 
of hydrolysed urine. The high specificity and sensitivity of the method enables 
the confirmation of different benzodiazepines in urine samples,£S7) 
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2.2.2 TRICYCLIC ANTIDEPRESSANTS 
2.2.2.1 Introduction 
Methods used for the analysis of tricyclic antidepressants in a forensic 
laboratory must be able to detect therapeutic levels and be applicable to small 
volumes of blood samples of poor quality. Many analytical methods have been 
applied to the separation of tricyclic antidepressants, and their metabolites from 
serum and plasma, but few satisfactory methods for the analysis of whole blood 
samples, such as those encountered in drugs/driving, murder, or rape cases, 
have been published. A successful method should facilitate the analysis of 
tricycliC antidepressants and their active metabolites without interference from 
coextracted endogenous materials present in blood. 
Many analytical methods have been applied to the analysis of tricyclic 
antidepressants in biological fluids. The assays generally preferred are by either 
enzyme-immunoassay[132,1331 or liquid chromatographic techniquesJl341 Enzyme 
multiplied immunoassay techniques (EMIT) with monoclonal antibodies is 
simple and easily adaptable to different automated analysers. However, at 
present, this technique is usable only for assays of first generation tricyclic 
antidepressant. Quantitative thin layer chromatography is another method 
usedJ135) GC has been used with flame ionisation detection, nitrogen 
phosphorous detection,fl04) electron capture detection,f1021 and mass 
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spectrometry,[135,136] Liquid chromatographic procedures have been published 
for both normal phase and reversed-phase columns.!147-139] 
2.2.2.2 Thin Layer Chromatography (TLC) 
Analysing for tricyclic antidepressants by thin layer chromatography 
(TLC) is either by quantitative or qualitative TLC. 
Quantitative TLC is relatively faster than other chromatographic 
techniques where more than eight samples are processed. Furthermore, the 
compounds separated on a TLC plate can be chemically converted to coloured 
or fluorescent products, a feature not readily and efficiently possible with liquid 
chromatography. Antidepressant drugs do not have strong UV absorption and, 
with the exception of Protriptyline, do not have strong native fluorescence. 
TLC has been applied in the 1980s for the determination of Imipramine 
and Desipramine.l140] In this procedure the specificity and sensitivity of 
detection has been increased by exposing the plate to nitrous acid fumes The 
resulting intense yellow spots are measured at 405 nm. While it appears that 
TLC is the most viable technique for the detection of antidepressant overdose in 
a majority of clinical laboratories, generally speaking, TLC does not have the 
required sensitivity to determine therapeutic concentrations of these drugs in 
plasma or serum. However, TLC has been quite useful for the screening of 
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antidepressants. Rf values, colours produced by these drugs with different 
reagents, e.g. Mandelin's reagent {perchloric acid))141,142J help in the 
identification of the drug. 
2.2.2.4 High Performance Liquid Chromatography (HPLC) 
Different types of reversed-phase and adsorption columns with different 
chemically bonded phases have been tested to separate many of the tricyclic 
antidepressants,[143J Following the introduction of chemically bonded phases 
for HPLC,[144.145] much attention has been focused on the analysis of drugs by 
reversed phase chromatography using a primarily aqueous mobile phase. 
Columns packed with a polar stationary phase such as unbonded silica or silica 
bonded with cyanopropyl groups (CN) have been used in the normal phase 
mode. The mobile phase in these procedures is polar and based upon water-
miscible solvents. Columns packed with a non-polar stationary phase, C8 or 
C1s silica, are preferred because of their long life unless a better separation can 
be achieved using an alternative stationary phase. With a given mobile phase 
retention of antidepressants on a CI8 column is greater than on a C8 column of 
the same brand. Therefore, a C8 column may be better than a C18 column for 
faster analysis. 
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A major failure offered by bonded-phase systems using aqueous eluents 
is the ability to analyse biological fluids either directly or following removal of 
colloidal material such as plasma protein.l146) 
An isocratic reversed-phase HPLC procedure was reported[87) for the 
simultaneous detection of Amitriptyline, Nortriptyline, Imipramine, 
Clomipramine and Desipramine in serum. Detection is achieved at 254 nm. 
The recovery of tricyclic antidepressants was 92 - 110% with a relative 
standard deviation of less than 5%. Another column switching system for the 
direct injection of plasma or serum samples, followed by isocratic HPLC and 
ultraviolet detection, is described for the simultaneous quantitation of the 
tricyclic antidepressant Amitriptyline and Nortriptyline. The method included 
adsorption of Amitriptyline and its metabolite as a reversed-phase Cs clean-up 
column. In plasma samples 'spiked' with 25 - 300 ng/ml, the recoveries were 
between 84 and 112%. There were linear correlations (> 0.99) between drug 
concentrations of 5 - 500 ng/ml. 
An analytical procedure was described in which a small volume of blood 
was taken (100 - 500 pI) and analysed using an OD5-Hypersil reversed-phase 
HPLC colurnnF9) 
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A method for the analysis of serum was reported.l1461 The extract was 
chroma to graphed on a cyano column and the absorbance was measured at 
215 nm. The mean analytical recoveries of tricyclic antidepressants added to the 
serum within the range 10 - 200 ].lg/L exceeded 90%. Antidepressants and 
other neuroleptics were measured in serum or plasma were detected by high 
performance liquid chromatography using octodecyclsilica column with a 
photodiode array detection.l1471 A method for the analysis of Amitriptyline and 
its metabolite Nortriptyline in a diasylate from blood plasma by HPLC without 
prior extraction with organic solvents has been reported.l148) The method is 
highly precise, easy to perform and seems suitable for determining the free 
fraction of drug in plasma.l149) The analysis was performed on a reversed-
phase spherisorb ODS Superpak cartridge 3 pm (100 mm x 4.0 mm LD]. 
A method for the analysis of both benzodiazepines and tricyclic 
antidepressants in serum has been described.l52) A 30% solution of acetonitrile 
in phosphate buffer containing dimethyloctylamine was used as a common 
isocratic mobile phase for the analysis of both benzodiazepines and TCA on a 
reversed-phase column and detection was 242 nm. The sensitivity limit of the 
assay was 25 mg/ml in serum with recoveries of 76 - 95% for tricyclic 
antidepressants. 
The analysis of tricyclic antidepressants was not only in plasma, serum 
and blood but also in mice brain,(1501 where a method was developed for the 
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assay of Amitriptyline, Amitriptyline-N-oxide, Nortriptyline, Desmethyl-
nortriptyline and its cis and trans-isomers in the plasma and the brain of mice 
using HPLC with ultraviolet detection (254 nm). The method was used to 
determine levels of Amitriptyline and its major metabolites in mice 30 minutes 
after a single administration of Amitriptyline (20 mg/kg). Other method were 
reported for the analysis of Amitriptyline, Nortriptyline, Imipramine in plasma 
or serum by reversed-phase liquid chromatographyJ151,1521 Other methods 
reported the use of CI8 columns. One method reported the use of reversed-
phase CI8 columns and the use of mobile phase containing l,S-diamino-octane 
(DAO) as amine modifier and heptanesulfonate as counter ion. This study 
demonstrated the high resolution anti selectivity of the chromatographic system 
compared to the mobile phases prepared with primary aminesJ1531 Some other 
methods reported the use of HPLC using reversed-phase CIS with ultraviolet 
detection for the determination of tricyclic antidepressants from biological 
samplesJ80,85,1541 
Another method was reported where the analysis was performed on two 
different Cs reversed-phase columns. One was TSK gel super-octyl, particle 
size 2 pm and the second was Hypersil MOS-CS with a particle size of 5 JIm. 
The results show that the new ODS column packing with a particle size of 2 JIm 
gives higher sensitivity and a shorter analysis than the conventional ODS 
column packing when applied to the analysis of biological samplesJ87J 
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2.2.2.4 Gas Chromatography (GC) 
Gas chromatography (GC) remams a highly sensitive and specific 
technique. For some applications, such as the determination of the free 
concentration of antidepressants, GC may be the only feasible technique. For 
chromatographic analysis, particularly for GC procedures, it is common 
practice to add one or more compounds as an internal standard to the sample to 
avoid precise measurement of volumes during extraction and analysis. There 
are exceptions, however. There is a report on the determination of 
Amitriptyline and Nortriptyline in rat brain by gas chromatography without 
the addition of any internal standard)155) Drugs usually need derivatization 
before their analysis on Gc. In general, there is a tendency for the absorption of 
primary and secondary amines on packed columns and to a lesser extent on 
capillary columns. This adsorption can be minimised by preparing suitable 
derivatives. However, there is a trend to avoid the preparation of derivatives 
even if it merely involves the addition of a few microlitres of a volatile reagent 
to the final extract prior to its evaporation. A majority of GC procedures for the 
determination of antidepressants published in the 1980s have used 1-2 m long 
packed glass columns. The liquid phase most commonly used for the GC 
separation of antidepressants remains OV-17 or an equivalent packing, SP-
2250.(156) Some reports on the use of quartz capillary columns with bonded 
liquid phases for GC determination of drugs has been reported.l157,158) 
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Helium is the recommended carrier gas used to exploit the high 
efficiency of the capillary columns. Use of hydrogen, which can provide even 
higher efficiency than helium, cannot be used with the commonly used 
detectors, nitrogen-phosphorous detector (NPD) and mass spectrometer, for the 
determination of antidepressants. Splitless injection provides high sensitivity 
and good reproducibility for the determination of antidepressants. 
Use of a flame ionisation detector (FID) for the determination of 
antidepressants was often used in the past. Methods have described a clean 
chromatogram for the determination of considerably low concentrations of 
Amitriptyline and its metabolites with the use of Flame Ionisation detectors. 
It has been shown that Nitrogen Phosphorous detection is the most 
suitable detector for GC detection of psychoactive drugs which are present in 
plasma in low concentrations. 
A method was described for the comprehensive screening and analysis of 
more than 80 basic compounds in blood and other biological specimens. This 
included Amitriptyline, Nortriptyline, Imipramine, Chlorpromazine and some 
other tricyc1ics,l73] The method was performed using l-Chlorobutane as the 
extracting solvent with GC analysis which as been developed and modified so 
that identification and quantification of as little as O.lllg/ml of virtually all 
basic drugs in blood can be accomplished in approximately one and one half 
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hours. Amitriptyline, Nortriptyline and Imipramine were extracted from 1 ml 
of serum, urine or other biological fluids under alkaline conditions, the 
resulting extracted aliquot of chloroform: isoamyl alcohol was injected onto a 
temperature programmed GC equipped with two nitrogen phosphorous 
detectors and two fused capillary columnJ1591 
Other methods were reported where the extracted drugs were analysed 
on GC with nitrogen phosphorous detection and have proven to be simple, 
quick, sensitive and comprehensive, requiring only a small amount of 
sampleJ69,1601 
Another method is the detection of tricyclic antidepressants in body 
fluids by GC with a surface ionisation detectorJ161) It is an extremely specific 
and sensitive method for organic compounds, such as secondary and tertiary 
amines that form their dissociative species at a low ionisation potential. The 
necessary equipment for surface ionisation detection is simply a modification of 
the standard thermoionic ionisation detectorJ1041. This method is more suitable 
for plasma or blood analysis than for urine analysis. Detection of tricyclic 
antidepressants in whole blood was reported, where head space solid phase 
extraction was performed, the vial was exposed to the headspace to allow 
adsorption of the drug and analysis was performed on capillary GC with flame 
ionisation detection. The detection limit of each drug was 16-
25 ng/O.5 mL.[162] 
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2.2.2.5 Gas Chromatography - Mass Spectrometry: (GC-MS) 
The mass spectrometer is the most sensitive and specific detector for Gc. 
Until recently, a mass spectrometer was available in only a few laboratories 
because of high initial and operating costs. Nvw a number of companies are 
marketing simplified bench top mass spectrometers which are adequate for 
drug analysis. 
Several GC-MS methods have been reported for the analysis of tricyclic 
antidepressants in different biological materials. 
A method was described for the analysis of TCA in urine and plasma, 
where a 10 ml sample of urine or a 1 - 3 ml plasma sample were extracted twice 
at pH3 and subsequently at pH10 with diethylether. The two extracts were 
combined and the organic layer solvent was evaporated with a dry stream of 
nitrogen. The residue was dissolved in 100 pI of methanol, 1- 3pl aliquot was 
used for GC-MS. Mass spectra were run on 4021 a GC-MS. Gas 
chromatography, with a fused-silica capillary column (25m x 0.32mm ID), was 
used with an injection port temperature of 290°C and an oven temperature 
programme at 75 - 300°C at 15°C/min. and the carrier gas was helium.l163) 
Other GC-MS methods were reported. One method was that the 
required samples were liquid-liquid extracted and dissolved in 50 pi of tertbutyl 
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methvlether. 1 J.11 aliquot was analysed by GC-MS in an electron impact 
mode.f lllO ] Another GC/MS method for the determination of tricyclic 
ntidepressants from whole blood was reported where both high recoveries and 
clean extracts were achieved. GC/MS used was equipped with a fused silica 
capillary column. In the electron ionisation mode (70 eV) scanning was from 
40 - 440 amu.fl64] 
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2.3 CHROMATOGRAPHIC ANALYSIS 
2.3.1 INTRODUCTION 
Chromatography is a method used for the separation of the components 
of a sample in which the components are distributed between two phases, one 
of which is stationary while the other is a mobile phaseJ165J It is a technique that 
enables samples of chemical mixtures to be separated by exploiting differences 
in their physical or chemical properties. These differences govern the rate of 
migration of the components of a mixture passing under the influence of a 
moving fluid through a bed of stationary phase. The individual components 
flow at different rates through the column, under the influence of the mobile 
phase. This action is known as the elution of the sample from the column. The 
differential rates of elution arise from interaction between the components of 
the sample and the material used to pack the column or a coating thereon. 
The interaction of a sample with the column packing is referred to as 
retention. The degree of retention is a characteristic of that sample, since this 
depended on the solubility, absorption, size and ionisation characteristic of that 
compound in the specific environment of that chromatographic system 
employed. 
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There are many forms of chromatography available. Since HPLC (High 
Performance Liquid Chromatography) and GLC (Gas Liquid Chromatography) 
are the techniques used in this study, they will be discussed here. 
Retention volume is a characteristic of a given sample and it is expressed 
as retention of a sample relative to the elution of a non-retained sample. This is 
referred to as the relative partition coefficient or capacity factor, K'. 
Equation 1. 
where Vo is the void volume, volume representing interstitial spaces 
between the particles packed in the column, VR is the sum of the void 
volume and the volume of mobile phase necessary to overcome the 
interactions between the sample and the column packing. 
When no change in the mobile phase occurs during the elution of the 
sample K' may be considered as: 
Equation 2. 
where tR and to are the retention times of a retained and non-retained 
sample. 
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For any separation to be possible, it is essential that each component has 
a different value for the capacity factor; each component must be retained to a 
different extent. In these circumstances the system is said to be selective 
towards the components being analysed. 
In chromatographic terms selectivity, a, is expressed as: 
Equation 3 
where K'a and K'b are the capacity factor for components a and b, tRa 
and tRb are retention times of peaks a and b, tRo retention time of non-
retained sample and a is the selectivity factor. 
The ability of a column to minimise peak spread is referred to as the 
efficiency of a column. The efficiency in all chromatographic techniques is 
expressed quantitatively as the number of theoretical plates, N, at the column. 
N = 16 (tR/Wb)2 Equation 4 
where Wb is the base width of the peak. 
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The characteristics of a column may be defined using the term height 
equivalent to a theoretical plate (HETP) which is referred to as the peak 
height, H. 
This is calculated by: 
H(mm) = length (mm)/N Equation 5 
Another characteristic of a column is defined by the resolving power, 
which related the width of eluted peaks to the distance between the peak 
maxima, the resolving power, or the resolution factor, 
Rl is calculated as follows: 
R = 2 (tRb - tRa) / (Wb + Wa) Equation 6. 
where tRa, tRb, Wa and Wb are the retention times and base width, 
respectively, of peaks a and b showing in Figure 12A. 
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Figure 12A: Schematic Diagram of GC and HPLC Chromatogram showing the 
Measurable Parameter. 
Wa and Wb = base widths of peak a and b 
= retention times of peak a and b 
= sum of half widths of the bases at the constructed triangles 
(the adjacent triangles just touch at the base line). 
R = resolution factor. 
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2.3.2 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
2.3.2.1 Reversed-Phase Chromatography 
Reversed-phase (RP) chromatography is the term used to describe the 
state in which the stationary phase is less polar than the mobile phase. 
Chemically bonded octadecylsilane (ODS), an alkane with 18 carbon 
atoms, is the most frequently used stationary phase in RP chromatography. 
Non-aqueous eluents are frequently used for the RP chromatography of non-
polar substances. The bonded phase columns are stable in the pH range (2 - 7) 
and at elevated temperatures. The classification of RP chromatography are 
discussed in reference 165. 
2.3.2.2 Normal Phase Chromatography 
Adsorption chromatography is referred to as normal phase chromatography. 
Normal phase chromatography involves interaction between adsorbent, 
usually silica, and the solvent molecules in solution. 
The mechanism of adsorption chromatography on the column packing is 
considered as a dynamic equilibrium, as shown in Figure 12B. The figure shows 
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that before a sample is introduced, a state of equilibrium exists whereby 
molecules of mobile phase are continually being adsorbed on the surface then 
subsequently desorbed; molecules of the sample and mobile phase compete for 
the adsorptive sites on the surface of the column packing. 
For the sample to be able to elute from the column, the adsorption of the 
sample must be represented by an equilibrium distribution with a small 
proportion of the sample being in the mobile phase. Discussion of normal 
phase chromatography is discussed in reference [1661. 
2.3.3 GAS CHROMATOGRAPHY (GC) 
2.3.3.1 Introduction 
Like all chromatographic techniques, GC separates mixtures by taking 
advantage of their components' differential distribution between two phases, 
one stationary phase, which is maintained at a defined temperature in an oven 
and has a constant flow of carrier gas. A sample of the mixture to be separated 
is introduced into the gas stream just before it encounters the stationary phase; 
the components are separated by elution and detected as they emerge in the gas 
at the other end of the column. They are distinguished by the different times 
which they take to pass through the column, the retention times. 
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The retention time of a substance is dictated by the position at its 
distribution equilibrium between the two phases. Therefore, separation of a 
mixture depends on its components having significantly different distribution 
equlibria. In order to be able to communicate GC retention data between 
laboratories independent of the instrument used, the concept of Retention Index 
(RI) has been introduced to GC analysis. The Retention Index is a measure of 
retention times in relation to standards that are analysed under the same 
conditions. 
The first RI system developed, and still widely used, is the Kovat's 
Retention Index (RIK). In this system, normal alkanes are assigned and 
RIKvalue at 100X carbon number. For Isothermal operation values are 
calculated according to the following expression: 
RIK = 100 [ logti'-logt'n ] + lOOn 
- logt'n+l-logt'n 
Equation 7 
where t'i = corrected retention time of sample peak [ti - t air], t'n = 
corrected retention time of normal alkane with carbon number N, which 
elutes before the samples peak, and t'n + 1 = corrected retention time of 
normal alkane with normal carbon number n + I, which eluted after the 
sample peak. 
Full discussion and the graphical representation of Kovat's Retention 
Index values is given in the literature.l166) 
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2.3.3.2 Gas Chromatographic Columns 
The GC column is the central item in a gas chromatograph. Two main 
column types are in common use - packed and capillary columns. The packed 
columns are used for 20% of GC analyses, and are used for simple preparations 
where high resolution is not required. Capillary columns of 0.25 and 0.53mm 
i.d. are the most popular, as are column lengths of 10 - 30m. The methyl 
silicones and polyethylene glycol stationary phases are the most preferred for 
capillary separations. The choice of phases for capillary columns is less than for 
packed columns, particularly for silica columns. However, the high efficiency 
available with a capillary column will often more than compensate for the lack 
of selectivity obtainable with a different phase. Bonded phases are divided into 
three: 
(i) Non-polar phases: Apiezon L (a hydrocarbon grease used for the 
separation of barbiturates), SE-30, OV-l, OV-IOI (and dimethyl 
silicone polymers separation on these phases are on the basis of 
molecular weight) and Apolone-87 (24, 24-diethyl-19,29-
dioctadecyl-heptatetracontane), is a high temperature non-chiral 
hydrocarbon phase. 
(ii) Polar phases: Carbowax 20M (is a polyethylene glycol which can 
be used for alkaloids and other basic drug separation), OV-17 
(phenylmethylsilicone, moderate polar silicone phase), XE-60 
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(cyanoethylsilicone, favoured for steroid analysis), OV-225 
(cyanopropyl phenylmethyl silicone), Polyesters (used for 
separation of fatty acids), Polyamides (Poly A103, used for 
separation of barbiturates and tricyclic antidepressants and 
Chirasil-Val (chiral phase used for the separation of enantiomers). 
(iii) Mixed phases: mixture of phases used to tailor a column to solve 
a particular problem. As an example separation of 11 commonly 
used anticonvulsant drugs can be achieved using a mixture of SP-
2110 and SP-251O-DA. 
The coating of the stationary liquid phase inside the capillary column can 
be in several forms: wall coated tubular column (WCOT); support coated open 
tubular column (SCOT); and fused-silica open tubular column (FSOT). The first 
column materials employed in the developmental stage of the technique were 
fabricated from plastic materials (Tygon and nylon) and metal (aluminium, 
nickel, copper, stainless steel and gold). Plastic capillaries, being thermoplastic 
in nature, had temperature limitations whereas metallic capillary columns had 
the disadvantage of catalytic activity. Today, the superior separations are 
achieved using fused-silica capillary column which, as an inert surface, yields 
better peak shapes; bands are sharper with less peak tailing, which facilitates 
trace analysis as well as provides more reliable quantitative and qualitative 
analyses. Full discussion on GC columns is discussed in the literature.l1661 
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2.3.4 GAS CHROMATOGRAPHY - MASS SPECTROMETRY (GC-MS) 
2.3.4.1 In trod uction 
Gas chromatography-mass spectrometry (GC-MS) instruments have been 
used for the identification of hundreds of components that are present in 
natural and biological systems. In this instrument, the gas chromatography 
provides the separation of compounds and introduces them to mass 
spectrometry through the interface. Mass spectrometry produce ions from a 
molecule, separates these ions as a function of their mass to charge (M/Z) ratios 
and records and displays the relative abundance of these ions. Figure 13 shows 
the basic component of a typical GC-MS system. 
More details of GC-MS are available in references 166-168 
2.3.4.2 GC/MS Interface 
The GC element leaves the column at atmospheric pressure whilst the 
MS ion source operates at 10-5 Torr. So for the direct connection of GC and MS 
the volume or pressure of the carrier gas must be reduced to avoid destroying 
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the high vacuum condition. The ideal interface device would remove all the 
chromatographic mobile phase and transfer all the solute to the ion source 
without degrading chromatographic elution. The flow rate of the capillary 
column is in the range of 0.5 - 3 ml/min which can be accommodated by the 
vacuum system of the MS while still maintaining a suitable pressure in the ion 
source. So it is possible to introduce the fused silica column directly into the ion 
source. All of the sample eluted from the GC enters the MS ion source. 
Mass spectrometry requires that molecules for analysis first be ionised. 
Two types of ionisation systems are available: Electron Impact (EI) and 
Chemical Ionisation (CI). Only one type will be discussed, electron impact. 
Electron Impact (EI) 
This is the most common method of ionisation in which electrons, 
obtained from a heated filament in vacuum, are accelerated through voltage (V) 
at 70V and directed across the ion chamber; the electrons thus have energy zV, 
where z is the electronic charge. A volatilized sample molecule (M) and an 
electron of energy greater than the ionisation energy of M will react if they pass 
close enough for the electron to impart sufficient of its energy to the neutral 
species. Not all of the energy of the electron is transferred. 
M+e 7 M+·+2e Equation 8 
where M+· represents a radical ion. 
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However, the reaction of an electron with a molecule is rather non-
specific. Positive-ion formation is accompanied by other processes such as 
electron capture and electronic excitation and those are represented by 
equations 9 and 10, respectively: 
M + e ~ M-' +e Equation 9 
M + e ~ M* + e Equation 10 
Less than 1 percent of the sample molecules are converted into positively 
charged ions. Ions with a life time more than 10-5 sec will be detected intact. 
Those with very short life times, less than 10-6 sec, will decompose in the source 
of the mass spectrometer and will not be detected. To monitor negative ions, 
the repeller plate and acceleration potential must be reversed in sign. 
2.3.4.3 Separation Of Ions 
After leaving the ion chamber, the ions are accelerated with an 
acceleration potential (V) into the mass analyser, the separation of ions 
according to their mass to charge ratios (m/ z) can be achieved with magnetic 
and electric fields alone or combined. Most of the basic differences between the 
various types of mass spectrometer lie in the manner in which such fields are 
used to effect separation. Those fields are magnetic-sector mass spectrometers, 
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quadrupole mass spectrometers, time-of-flight mass spectrometers and ion 
cyclotron resonance mass spectrometers. 
2.3.4.4 Ion Detection And Data Analysis 
There are four main ways of detecting ions: by photographic plate, 
Faraday cup or electron multiplier. They all work differently but in the simplest 
detector, ions impinge on a metal plate which is connected to earth through a 
resistor. The resulting neutralisation of the charge on the ions leads to a flow 
current through a resistor which can be detected and affords a measure of ion 
abundance. The commonest detector is the electron multiplier which consists of 
a series of about ten electrodes. When an ion impinges on the first electrode, it 
causes the release of a shower of electrons to the second electrode and each of 
these electrons causes a further shower of electrons at the third electrode. This 
cascading effect continues through the whole series of electrodes and provides 
gains of the order of 106. The amplified signals from the detector are passed to a 
recorder and the signals are used to deflect mirror galvanometers of different 
sensitivities. At a more sophisticated level, these electrical signals are passed 
indirectly via a magnetic tape recording, or directly to a computer which 
evaluates the incoming data and prints out the required information. 
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2.4 EXTRACTION TECHNIQUES 
2.4.1 SOLID PHASE EXTRACTION 
2.4.1.1 Introduction 
Over the past decade, sorbent extraction has emerged as a powerful tool 
for chemical isolation and purification. It plays an important role in a broad 
range of applications: pharmaceutical, fine chemical, biomedical, food analyses, 
organic syntheSiS, environmental, and many othersJ169-171] Sorbent extraction is 
a physical extraction process that involves a liquid and a solid phase. In sorbent 
extraction the solid phase has a greater attraction for the isolate than the solvent 
in which the isolate is dissolved. As the sample solution passes through the 
sorbent bed, the isolate concentrates on this surface, whilst the other sample 
components pass through the bed. Very selective extractions resulting in highly 
purified and concentrated isolates can be achieved by choosing sorbents with an 
attraction for the isolate but not for the sample components. Sorbents are 
formed by the reaction of organosilanes with activated silica. The product is a 
sorbent with the functional group of the organosilane attached to the silica 
substrate through a silyl ether linkage. 
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The bonded silica sorbent product is stable within a pH range of 
approximately 2 - 7.5. Above pH 7.5 the silica substrate is susceptible to 
dissolution in aqueous solutions. Below pH 2.9 the silyl ether linkage is labile, 
and the functional groups on the surface will begin to cleave. In practice, 
bonded silica may be used for sorbent extractions in a pH range of 1 - 14, since 
degradation of the sorbent is a finite process and sorbents are typically exposed 
to solvent for only short periods of time. 
Bonded silica sorbents are rigid materials that do not shrink or swell in 
different solvents, unlike many polystyrene based resins. For this reason, 
bonded silicas equilibrate rapidly to new solvent conditions. This allows 
complex extraction procedures involving many different solvent changes to be 
performed rapidly. The silicas most commonly used in making bonded silica 
sorbents have a particle size distribution of 15 - 100 microns. The particles are 
irregular rather than spherical. 
The nominal porosity of most of the sorbents is 60 Angstroms, adequate 
for compounds with molecular weights up to approximately 15,000 to pass 
through the sorbent. 
At the microscopic level, a silica sorbent resembles a forest of functional 
groups anchored through a root system of siloxane bridges. These bonds, and 
the silica beneath are responsible for two important properties of silica sorbents: 
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the need for solvation of the materials, and the potential for secondary 
interactions with isolate molecules. 
Solvation of a sorbent is necessary before the sorbent will interact 
reproducibly with isolates. Solvation simply means that a solvent is passed 
through the sorbent to wet the packing material and to solvate the functional 
groups of the sorbent. Retention is accomplished by passing several bed 
volumes of a suitable solvent. The adsorptive or retentive properties of a 
bonded silica are due principally to the functional groups bonded to the silica 
substrate and any unbounded silanols remaining on the surface. Interactions 
between the substrate and isolate molecules are called secondary interactions. 
When there is an attraction between the sorbent and isolate molecules, causing 
the isolate to be immobilised on the sorbent surface as the sample solution 
passes through the sorbent bed. This phenomenon is called 'retention' whilst 
the process by which an isolate is removed from a sorbent bed on which it has 
been retained is called 'elution'. 
Capacity of a given sorbent is defined as the total mass of a strongly 
retained isolate that can be retained by a given mass or sorbent under optimum 
conditions. Bonded silica ion exchange sorbents typically have capacities of 0.5 
to 1.5 meq/ g. For other sorbents, capacity values range from less than 1% to as 
high as 5%. That is, 100 mg of sorbent might retain as much as 5 mg of a 
strongly retained isolate. 
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Selectivity is the ability of the sorbent to discriminate between the isolate 
and all other sample matrix components. It is a function of three parameters: 
the chemical structure of the isolate, the properties of the sorbent, and the 
composition of the sample matrix. Maximum selectivity is achieved when a 
sorbent is chosen that interacts through isolate functional groups that are not 
common to other matrix components. 
2.4.1.2 Non-Polar Interactions 
Non-polar interactions are those that occur between the carbon-hydrogen 
bonds of the sorbent functional groups and the carbon-hydrogen bonds of the 
isolate. For many sorbents non-polar interactions are of lesser importance 
because a predominance of other functional groups mask the non-polar aspects 
of the sorbent. All isolate species have a potential for non-polar interactions. 
Exceptions include inorganic ions and compounds, e.g. carbohydrates 
whose structure contains so many polar or ionic groups that the carbon 
structure of the molecule is masked. 
Non-polar interactions are very effective for isolating groups of 
compounds that are not similar in structure. Retention of isolates by non-polar 
interaction is facilitated by polar solvents. 
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On the other hand, non-polar interactions between the isolate and the 
sorbent are best disrupted by solvents having some degree of non-polar 
character. 
Octadecyl Silane CIS 
The most widely used sorbent for non-polar interactions is octadecyl 
silane bonded to the silica substrate. Many isolate molecules can be retained by 
it. CI8 is a very non-selective sorbent. 
2.4.1.3 Polar Interactions 
Polar interactions are exhibited by many different sorbents and 
functional groups on isolates. Polar interactions include hydrogen bonding, 
dipole/ dipole, induces dipole/dipole, pi-pi, and a variety of other interactions 
in which the distribution of electrons between individual atoms in the 
functional groups is unequal, causing positive and negative polarity. Groups 
that exhibit these types of interactions typically include hydroxyls, amines, 
carbonyls, aromatic rings, sulfhydryl, double bonds and groups containing 
hetero-atoms such as oxygen, nitrogen, sulphur and phosphorus. Retention of 
isolates by polar interactions is facilitated by non-polar solvents. 
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Elution of isolates from polar sorbents is facilitated by polar solvents, and 
high ionic strength. 
Activated Silica (SI) 
Silica is generally regarded as the most polar sorbent available. 
Unbounded, activated silica is also fairly acidic. The extreme polarity of silica 
accounts for its ready adsorption of water and a very polar solvent such as 
methanol S1 is one of the best sorbents available for selectively separating 
isolates at a very similar structure. 
Aminopropyl (NH2> 
Like many of the ion-exchange sorbents, NH2 is capable of exhibiting all 
possible interactions. NH2 is a very polar sorbent, and a strong hydrogen 
bonder that also can function as an anion-exchanger. Thus, analytes have the 
opportunity to interact not only with the bonded phase but also with the 
underlying silica sorbent. Furthermore, because the hydrocarbon chain is short, 
only three carbons in length, the bonded phase may interact with the 
underlying silica through hydrogen bonding. Since the pKa of the NH2 sorbent 
is 9.8, at any pH below 9.8 NH2 is positively charged. 
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Although NH2 has been used for non-polar isolations from polar 
solvents, its extreme polarity makes its non-polar character less significant than 
its other properties. Normal phase sorbents are good sorbents for the extraction 
of tricyclic antidepressants since they have amines in their structure which can 
interact with the functional groups of the sorbents, but it is not the sorbent of 
choice for the extraction of benzodiazepines which are considered as weak basic 
compounds that interact weakly with the functional groups at the polar 
sorbents. 
2.4.1.4 Ionic Interactions 
The interaction occurs between an isolate molecule carrying a charge 
(either positive or negative) and a sorbent carrying a charge opposite to that of 
the isolate. Groups of isolates and sorbents that can exhibit ionic properties 
allowing ion-exchange interactions can be divided into two classes: groups that 
can be cationic (positively charged) including primary, secondary, tertiary and 
quaternary amines; and inorganic cations such as calcium, sodium and 
magnesium. 
Anionics (negatively charged) include carboylic and sulfonic acids, 
phosphates and other similar groups. 
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Retention of isolates by ion-exchange interaction is facilitated by 
solvent/matrix pH between the pKa of isolate and sorbent, while elution of 
isolates from ion-exchange sorbents is facilitated by solvent/matrix pH above 
pKa of cation or below pKa of anion. 
Carboxymethyl (CBA) 
CBA is a medium polarity sorbent, exhibiting either polar or non-polar 
interactions depending on the solvent environment. 
One of the most useful characteristics of CBA is its weak cation-exchange 
properties. The most commonly encountered cations in organic isolates are 
amines. 
CBA has a pKa of 4.8, above a pH of 4.8. CBA carries a negative charge 
that can be used for retaining cationic isolates. Dropping the pH below 4.8 
neutralises the CBA, permitting the retained isolates to elute from the sorbent. 
For this reason, CBA is often the best choice for cation exchange especially when 
dealing with very strong cations (i.e. high pKa cations). 
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Propylbenzenesulfonyl (sex) 
sex is a strong cation-exchange with a very low pKa, due to the presence 
of the benzene ring on its surface. sex has a high potential for non-polar 
interactions. This dual nature is useful with isolates that exhibit both cationic 
and non-polar character. After retaining the isolate, the sorbent can be washed 
with non-polar solvents and with high ionic strength solvents without 
displacing the isolate from the sorbent. The isolate can be eluted from the 
sorbent with a solvent that disrupts both ionic and non-polar interactions 
simultaneously, such as methanolic hydrochloric acid. 
CN Sorbent (Cyanopropyl): 
A medium polarity sorbent, eN can be used as a polar sorbent for 
analytes that might be retained irreversibly on the more polar sorbents, such as 
silica or dial. The cyano group provides a unique selectivity which can be 
moderated by intelligent use at eluting solvents. 
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CHAPTER 3 - EXPERIMENT 
3.1 DRUGS SPIKING 
Blank blood, supplied by the Scottish Blood Transfusion Service, was 
tested for the presence of drugs under investigation and was found to be 
negative. Portions of this blood were transferred into clean vials, sealed and 
designated as blank blood. Other portions were 'spiked' with the drugs under 
investigation, transferred into clean vials and sealed. Both lots were then stored 
under the same conditions. The concentration of drug in the blood was set to 
levels of each of the drugs under investigation where toxic effects had been 
found. At the day of spiking, a sample of 'spiked' blood was analysed to 
measure the concentration of the drug on that day. This was designated as the 
day zero concentration. 
3.1.1 BENZODIAZEPINES 
A stock of standard solution of Diazepam, Desmethyldiazepam, 
Temazepam and Triazolam was made up in methanol at a concentration of 
50 llg/ml, 30 llg/ml, 50 llg/ml and 300 llg/ml, respectively. 36 ml of each of 
the above solutions were transferred into clean conical flasks and evaporated to 
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dryness under a stream of nitrogen gas on a hot block 60°C. Each solution of 
Diazepam, Desmethyldiazepam, Temazepam and Triazolam was redissolved in 
360ml of blood to produce a concentration of 5.0 llg/ml, 3.0 llg/ml, 5.0 llg/ml 
blood and 50 llg/ml of blood. 15ml aliquots were transferred into clean 
hypovials of 25 ml capacity and sealed with a butyl rubber septa. 
3.1.2 TRICYCLIC ANTIDEPRESSANTS 
A 20 ml of a stock standard solution of 100 llg/ml of each of 
Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine in methanol was 
transferred into a conical flask and evaporated to dryness under a nitrogen 
stream on a hot plate at 60°C. Each flask containing each of the above drugs 
was redissolved in 200 ml of blank blood and mixed thoroughly using a 
magnetic stirrer. The resulting concentration for each of the above drugs, in 
blood was 10 llg/ml. 5 ml of the 'spiked' blood was transferred into clean 6 ml 
capacity hypovials which were sealed with a butyl rubber septa. 
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3.2 DRUGS STORAGE 
Two vials for each required measurement of 'spiked' blood for each drug 
and blank blood were stored at different temperatures and periods of time 
before re-analysis to measure the effect of the temperature and the time interval 
on the drug concentration. The interval of time between each analysis was 
designated as one, two, three and up to twelve months. The drugs were stored 
at soc, 2SoC and -20°C. Two samples each of 'spiked' blood and blank blood of 
each drug were removed from storage, opened and analysed at each designated 
period of time. These samples were then discarded. 
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3.3 TEMPERATURE MONITORING OF 'SPIKED' SAMPLES 
The storage temperature of the 'spiked' blood (with drug) and blank 
blood under study were monitored from the day of spiking until the end of the 
experiment. Storage temperature was monitored over different time intervals 
(hours, days, months) at the storage temperatures SoC, 2SOC and -20°C. 
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3.4 DRUGS EXTRACTION 
3.4.1 BENZODIAZEPINE 
3.4.1.1 Extraction Buffer Preparation 
Disodium hydrogen orthophosphate dihydrate (Na2HP04.2H20, m.wt 
177.99) buffer was made up by dissolving 1.78 grammes of Na2HP04.2H20 in 
deionised water and making up to one litre. The resulting buffer concentration 
of 0.01 M was adjusted with a few drops of orthophosphoric acid (Na3P04) to 
pH 7. 
3.4.1.2 Standard and Internal Standard Solutions: 
A stock solution containing the four benzodiazepine drugs (Triazolam, 
Temazepam, Desmethyldiazepam and Diazepam) was prepared by dissolving 
2 mg of each drug in a few drops of methanol and then diluting to 100 ml with 
deionised water to produce a stock standard solution of 20 llg/ml. Further 
dilution with deionised water was made to produce a working solution of 
9pg/ml. 
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The internal standard solution (Prazepam) was prepared by dissolving 
2 mg in a few drops of HPLC grade methanol and making up to 100 ml with 
deionised water, the resulting concentration being 20 }lg/ml. 
The same preparation were used for the method development for all 
solid phase extraction procedures that follow. 
3.4.1.2.1 eN Sorbent/Sample Preparation: 
0.9 ml of deionised water was transferred to a 6 ml screw-capped vial. 
The following solutions were added: 
1. 0.1 ml of the working standard mixture of benzodiazepine drugs 
(911g/ml). 
2. 0.1 ml of internal standard (Prazepam 20 llg/ml) 
3. I ml of O.OIM disodium hydrogen orthophosphate buffer (pH 7) 
The vial was mixed well and the samples were extracted as follows: 
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3.4.1.2.2 Sample Extraction: 
CN (Cyanopropyl) columns of 3 ml capacity were used. The columns 
were preconditioned with 3 x 1 ml of methanol, followed by 3 x 1 ml deionised 
water under a light vacuum (approximately SmmHg) and followed by 3 x 1 ml 
(O.01M, pH 7), disodium hydrogen orthophosphate dihydrate buffer. The 
vacuum was turned off when the phosphate buffer was close to reaching the 
top of the sorbent bed to prevent the sorbent running dry. 
3.4.1.2.3 Addition of Sample: 
The above mixture (3.4.1.1.1) was transferred to pre-conditioned Bond 
Elut eN columns and drawn slowly through under vacuum. The vacuum 
pressure generated by the water pump was kept between 5 - 10 PSI. The 
cartridge was not allowed to dry out. 
The sorbent was washed twice with 1 x 1 ml O.OIM Na2HP04 (pH 7) and 
dried by passing air for 30 - 40 seconds. 
3.4.1.2.4 Elution of the Sample 
The drugs were eluted from two sorbents using different elution solvents: 
1. Acid methanol (25 pI 1 % H3P04 in 5 ml methanol). 
2. Methanol. 
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3.4.1.2.5 Analysis of the Sample 
The eluent was evaporated to dryness by placing the vial on a hot plate 
at 60°C under a nitrogen gas stream. The extract was reconstituted in mobile 
phase (O.OIM disodium hydrogen orthophosphate dihydrate) 
(Na2HP04.2H20, m.wt 177.99) (pH 8.8) and methanol in the proportions 
(30: 70 v Iv) was used. 20}II was injected on to the HPLC system. 
3.4.1.3 Bond Elut Certify Sorbent 
Another solid phase extraction method was used where Bond Elut 
Certify columns were used. This column contains a proprietary bonded silica 
sorbent, which exhibits a unique hydrophobic ion exchange extraction 
mechanism and will retain benzodiazepine drugs under the proper extraction 
condi tions. 
3.4.1.3.1 Sample Preparation 
Blood samples (1 ml) were 'spiked' with a working standard mixture of 
benzodiazepine drugs (9 }Ig/ml).,was sonicated in a sonic bath for 15 minutes 
at room temperature. The samples were then diluted with 6ml of phosphate 
buffer (pH 6.0) and vortex mixed for 30 seconds. The buffered matrix was then 
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centrifuged at 5000x g for 10 minutes, and then the supernatant was used or 
further extraction .. 
3.4.1.3.2 Sample Extraction 
Bond Elut Certify Columns of 1 ml capacity were used. They were 
conditioned with 2 ml of methanol, followed by 2 ml O.lM phosphate buffer 
(pH 6.0) under light vacuum, approximately 2 PSI. 
3.4.1.3.3 Addition of Sample 
The prepared sample (3.4.1.2.2) was applied onto the column and drawn 
through completely at a flow rate of approximately 1.5 ml/min. The columns 
were washed with 1 ml deionised water. The columns were acidified by 
passing through 0.5 ml of O.OlM acetic acid. Then the columns were dried 
under full vacuum (15 PS.I) for 4 minutes, methanol (50 pI) was added and the 
columns were dried under full vacuum for 1 minute. 
3.4.1.3.4 Elution of Sample 
2 ml of 2% ammoniated ethylacetate was added to each column and 
eluted completely at a flow rate of 0.5 ml/min. The eluates were evaporated to 
dryness under a nitrogen stream and reconstituted in 100 III mobile phase. 
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20 J.1l was injected into HPLC. Mobile phase is composed of 0.01 M Na2HP04 
(methanol 30 : 70 v Iv). 
3.4.1.4 Cationic Exchange Sorbent (SeX) 
The sex cartridges of 3 ml capacity were conditioned under vacuum 
with methanol (2 ml), water (1 ml) and 10 mM phosphoric acid (pH 3.4,0.5 ml). 
The 'spiked' whole blood samples (9 ].1g/ml) with the four benzodiazepine 
drugs (Diazepam, Temazepam, Triazolam and Desmethyldiazepam) and 10 
mM phosphoric acid (0.5) were mixed thoroughly and applied to the column. 
The column was air dried for approximately 30 seconds and then washed with 
10 mM phosphoric acid (1 ml), 0.1 M acetic acid (0.5 ml) and methanol (1 ml) . 
3.4.1.4.1 Elution of Sample 
Ammoniacal methanol (3%) (2ml) was used for elution, it was passed 
through the column and collected. 
The eluate was evaporated to dryness under nitrogen at 45°C and 
reconstituted in 50 ].11 of mobile phase, 10 ].11 of which was analysed by HPLC. 
Mobile phase used was Na2HP04 (O.01M) : methanol 30 : 70 v Iv. 
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3.4.1.5 Bond £lut Cs Sorbent 
The method of choice for blood extraction of benzodiazepine drugs is the 
following. The method was chosen due to its high recovery and its 
reproducibility. Dry extraction of the blood 'spiked' with benzodiazepine 
drugs at the different storage conditions (5°C, 25°C and -20°C). 
Two vials of the 15 ml aliquots of 'spiked' blood with different drugs and 
a vial of blank blood is taken out each month from its storage place (5°C, 25°C 
and -20°C), extracted and analysed for the variation in concentration of drugs at 
different conditions. 
3.4.1.5.1 Extraction Buffer Preparation 
The extraction buffer used was a mixture of acetonitrile : methanol 
water in the following ratio - acetonitrile: methanol: water (30:35:35 v Iv Iv). 
3.4.1.5.2 Internal Standard Preparation 
The internal standard preparation (Prazepam) was prepared by 
dissolving 2 mg with a few drops of HPLC grade methanol and making up to 
100 ml with deionised water, the resultant concentration being 20 l1glml. 
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3.4.1.5.3 Sample Preparation 
1. 1.0 ml of whole blood samples containing the four drugs 
(Diazepam, Desmethyldiazepam, Temazepam and Triazolam) at a 
concentration (911g/ml). 
2. 0.1 ml of internal standard (Prazepam 20 llg/ml). 
3. 1.0 ml of O.01M disodium hydrogen phosphate (pH 10.4). 
-t. 1.0 ml of 2% ammonia solution (NH3 35%). 
The tubes were mixed well. Six samples of 'spiked' whole blood were 
extracted through a Bond Elut C8 column of 3 ml capacity. 
3.4.1.5.4 Extraction Procedure 
Bond Elut C8 cartridges (3 m1 capacity) were attached to a Vac-Elut Box. 
Vacuum was applied using a water pump and the cartridges were conditioned 
by drawing the following solutions through: 
3 x 1.0 ml of HPLC grade methanol, 
followed by 3 x 1.0 ml deionised water, 
followed by 3 x 1.0 ml O.01M disodium dihydrogen 
orthophosphate pH 10.4] 
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3 .... 1.5.5 Addition of Sample 
The prepared sample was transferred to the preconditioned Bond Elut 
C8 column and was drawn through under vacuum (the vacuum pressure 
generated by the water pump was kept between 5-10 PSI and the cartridge was 
not allowed to dry out between applications. Then the column was washed 
twice with 1 ml of .00M Na2HP04 (pHlO.4) followed by 2 ml HPLC grade 
hexane. The blank sample prepared (3.4.1.4.3) was drawn through under 
vacuum (pressure 5-10 PSI), then the column was washed as above. 
3 .... 1.5.6 Elution of Sample 
The sorbent was washed twice with 2 ml of .01 M Na2HP04 ( pH 10.4) 
and final elution of the drugs was performed with 1 x 5 ml chloroform. 
3 .... 1.5.7 Analysis of the sample 
The extract was evaporated to dryness by packing the vial on a hot plate 
60°C under a stream of nitrogen gas. The residue was redissolved in mobile 
phase (O.lml) [3.4.1.1 ]. 20 III was injected onto the HPLC. 
3.4.1.6 Blood Extraction for Stability Study 
Blood extraction of the 'spiked' blood with the four drugs (Diazepam, 
Desmethyldiazepam, Temazepam and Triazolam) was performed each month 
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at the three different temperatures (5, 25 and -20°C) by using a Cs bonded 
phase column of 3 ml capacity. 
Two vials of the 15 ml aliquots of the 'spiked' blood with the different 
drugs and a vial of blank blood was taken out each month from its storage 
place (5°C, 25°C and -20°C), extracted and analysed for the variation of drugs 
at different conditions. 
3.4.1.6.1 Sample Preparation 
1. 1.0 ml of each 'spiked' blood sample with the four 
benzodiazepines. 
2. 0.1 ml of internal standard (Prazepam llg/ml). 
3. 1.0 ml of O.01M disodium hydrogen phosphate (pH 10.4). 
4. 1.0 ml of 2% ammonia solution (NH3 35%). 
Then the tubes were mixed well. Twenty four samples of 'spiked' stored 
blood at the three different temperatures (5°C, 25°C and -20°C) were extracted 
through Bond Elut Cs Columns of 3 ml capacity. 
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3.4.1.6.2 Blank Preparation 
1. 1.0 ml of blank blood sample. 
2. 1.0 ml of O.01M disodium hydrogen phosphate (pH 10.4). 
3. 1.0 ml of 2% ammonia solution (NH3 35%). 
The tube was mixed well. The three samples taken from the three 
different storage conditions were extracted through Bond Elut columns of 3 ml 
capacity. 
Extraction, addition, elution and analysis of samples as described in 
3.4.1.4.4., 3.4.1.4.5 ,3.4.1.4.6. and 3.4.1.4.7. 
3.4.1.7 HPLC System for Benzodiazepine Analysis 
The method used for Benzodiazepine drugs (Triazolam, Temazepam, 
Oesmethyldiazepam) analysis was high performance liquid chromatography 
based on a Pye Unicam pump (ModeI4015).This was used to deliver the mobile 
phase at a flow rate of 1 mIl min. Drugs were detected using a Pye 4025 variable 
wavelength ultraviolet detector set at 230 nm to monitor the column eluent. 
The column used was 25 cm x 4.5 mm internal diameter (1.0) and guard 
column 5 cm x 4.6 mm (1.0). Both were pre-packed with Hypersil 5 ~m 
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octadecylsilane C18, 20 Jll extracts were introduced using a Rheodyne 7125 
injection port with a 20 Jll loop. The chromatograms were recorded on a BBC 
Goerz Metrawatt SE120 chart recorder operated at 1 cm/minute and 10mV full 
scale deflection. 
3.4.1.8 Mobile Phase Preparations 
Different preparations of mobile phases were tried for the analysis of 
benzodiazepines on HPLC system: 
0.1 Na2HP04:methanol (25:75 V IV), as described by reference 172. 
The pH of the mixture was 8.8. 
O.lM Phosphate buffer was prepared by dissolving 0.53 grammes 
of disodium hydrogen phosphate hexahydrate and 8.93 grammes 
of potassium dihydrogen with a few millilitres of phosphate in 
water, the pH of the mixture was adjusted with orthophosphoric 
acid to pH5.4 then made up to 1 litre with deionised water. 
The two mixtures tried were: 
1. 38 : 62 V /V (Acetonitrile: phosphate buffer) pH .4. 
2. 70 : 30 V /V (Acetonitrile: phosphate buffer) pH 5.4. 
3.4.1.9 
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O.IM Na2HP04.2H20, MW 177.99) Disodium hydrogenorto-
phosphate dihydrate; the buffer was made up by dissolving 
1.78 grammes of Na2HP04.2H20 in deionised water. The 
resulting buffer concentration of O.OlM was adjusted with a few 
millilitres of IN sodium hydroxide (NaOH) to pH 10.4, then it 
was made up to 1 litre with deionised water. 
Disodium hydrogen orthophosphate dihydrate, Na2HP04.2H20, 
MW 177.99 was made up by dissolving 3.56 grammes of 
Na2HP04.2H20 in deionised water, the resulting buffer 
concentration of 0.2M was adjusted with a few millilitres of 
orthophosphoric acid to pH 6 and was made up to 1 litre using 
deionised water, 80 ml of the latter was mixed with 100 ml of 
methanol and 8 ml of 1-propanol. 
The mobile phase of choice was a mixture of Acetonitrile: 
Methanol: Water, 30:35:35 (v Iv Iv). 
Reproducibility of the HPLC System 
A standard solution of 1 pg/ml of each of Diazepam, 
Desmethyldiazepam, Temazepam and Triazolam was prepared in mobile 
phase. The reproducibility of the HPLC was determined by injecting six 
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injections at each of the standards of Diazepam/ Desmethyldiazepam/ 
Triazolam and Temazepam (1 llg/ml ), each day, over three successive days 
under the same conditions. Flow rate = 1.0 ml/min, Range (AVFS) = 0.32, 
Chart Speed 1 em/min and a wavelength = 230 nm. 
3.4.1.10 Reproducibility of the Extraction Method 
Thirty samples of blood 'spiked' with the four benzodiazepine drug 
mixture (Triazolam, Temazepam, Desmethyldiazepam and Diazepam) in a 
concentration of 0.911g/ml of blood were extracted through Bond Elut C8 
columns, 3 ml capacity, and analysed over three successive days. The peak 
height ratio of drug against the internal standard Prazeparn (20 llg/rnl) was 
used to calculate the day-to-day variation of the extraction and analysis method 
of the four benzodiazepines using HPLC system. 
3.4.1.11 Calibration Curves (Linearity) 
The peak height ratio of each benzodiazepine drug was plotted against 
its concentration over a concentration range from low (O.lllg/ gramme), to 
subtherapeutic (0.2 llg/ gramme), and to therapeutic (0.9-2.0 llg/ gramme). 
Standard mixtures were prepared with concentrations ranging from O.Olllg to 
2 llg/ gramme to find the detection limit for each drug. The above 
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concentration ranges included the subtherapeutic, therapeutic, toxic and fatal 
levels. 
3.4.2 TRICYCLIC ANTIDEPRESSANTS 
Introduction 
Different solid phase extraction methods have been tried to obtain 
optimum recoveries of the four drugs of interest (Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine) from whole blood. Some of the methods 
tried needed a multistep extraction and others had short extraction steps. The 
best method of extraction that took only a few steps and gave good recoveries 
was used as the method of extraction for the stability study. 
3.4.2.1 Solid Phase Extraction 
3.4.2.1.1 C18 Bonded Phase Extraction 
3.4.2.1.1.1 Protein Precipitation Methods 
Removal of protein by precipitation is an effective method of sample 
preparation. The advantages of this technique are the speed at which the 
sample can be prepared and its simplicity. Different sample pre-treatment 
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procedures were used before extraction of the samples especially when using 
solid phase extraction methods)95,'J8] 
3.4.2.1.1.2 Sample preparation 
1 ml of whole blood sample 'spiked' with the four tricyclic 
antidepressants (Amitriptyline, Nortriptyline, Imipramine and 
Chlorpromazine) at a concentration of 100 pg/ml for the four drugs was mixed 
with 3 ml of methanol, vortexed for one minute and then centrifuged for five 
minutes at 1300 rpm. 1 ml of supernatant was mixed with 200 pI of the internal 
standard papaverine (0.5 mg/ml) diluted with 1 ml of distilled water and 
vortex mixed for 20 seconds. 
3.4.2.1.1.3 Sample Extraction 
The bonded phase columns used were CI8 extraction columns with a 
100 mg capacity and a 40 pm particle size. 
The columns were conditioned firstly by washing with 3 ml of 600 pI of 
diethylamine in 100 ml of HPLC grade methanol under a vacuum of 
254 mm Hg. 3 ml of a second conditioning buffer, which was prepared by 
dissolving 1 g of potassium bicarbonate in 100 ml of 10% acetonitrile in water, 
was applied to the column and allowed to drain under vacuum. The sample 
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prepared as in 3..1,.2.1.1.2 was applied to the column and allowed to drain under 
a vacuum of 254 mm Hg. The columns were then washed three times with 1 ml 
of acetonitrile: water (20: 80). After the last wash the columns were left under 
vacuum for two minutes. 
3.4.2.1.1.4 Sample Elution 
The elution reagent used was prepared by dissolving 600 pI of 
diethylamine in 100 ml of HPLC grade methanol. 
2 x 300 pI portions of the above reagent were used to elute the drugs. 
The combined eluents were evaporated under a stream of nitrogen. The 
residue was reconstituted with 50 pI methanol. 1 pI was injected into the gas 
chromatography unit. 
3.4.2.1.2 ~ Bonded Phase Extraction 
3.4.2.1.2.1 Sample pre-treatment 
Whole blood samples 'spiked' with the four drugs, Amitriptyline, 
Nortriptyline, Imipramine and Chlorpromazine, at 100 pg/ml for the four 
drugs was centrifuged at 3000 rpm for 10 minutes. 1 ml of the plasma obtained 
was aspirated for further sample preparation procedure. 
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3.4.2.1.2.2 Sample Preparation 
The 1 ml supernatant obtained was prepared by mixing it with a 30 pI 
aliquot of 500 pg/ml solution of the Papaverine ir,ternal standard was added. 
This mixture was vortexed slightly before proceeding with the extraction. 
3.4.2.1.2.3 Extraction Column Preparation 
Cs bonded phase extraction columns were prepared by sequential 
washing with 1 ml of methanol, 1 ml of distilled water, 1 ml of 0.25% sodium 
carbonate and, finally, with 1 ml of 0.2 M orthophosphoric acid. The columns 
were not allowed to dry between preparation and use .. 
3.4.2.1.2.4 Extraction of Samples 
To the prepared plasma samples 50 pI of 3M orthophosphoric acid was 
added and the solutions were vortexed again briefly. Each sample was pipetted 
and added into the prepared extraction column. The column was then washed 
with 1 ml of water and then further washed with 1 ml of 0.25% sodium 
carbonate. 
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3.4.2.1.2.5 Elution of Samples 
The analytes were eluted with 2 x 150 pI aliquots of methanol. After 
thoroughly mixing with two aliquots in clean vials. The samples were 
evaporated to dryness under nitrogen gas. The residue was reconstituted with 
50 pI methanol and 1 pI was injected into the gas chromatography unit. 
3.4.2.2 Liquid-Liquid Extraction Methods 
In order to have a screening procedure by gas chromatography that was 
simple, quick, comprehensive and required only a small amount of sample, 
different liquid-liquid extraction procedures were tried before deciding which 
was the best extraction procedure for the stability study. Some of these 
procedures needed a multi-step extraction and others needed only a one-step 
extraction. 
3.4.2.2.1 Sample Extraction Using l-Chlorbutane 
A 2 ml sample of blood 'spiked' with each of the four drugs of interest 
(Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine) at a 
concentration of 100 pg/ml was placed in a 10 ml culture tube to which was 
added 4 ml l-chlorobutane. Each sample was extracted for five minutes on a 
rotator. After centrifugation, 4 ml of the upper l-chlorobutane layer was 
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transferred to another culture tube to which was added 2 ml (LON) Hel. The 
sample was extracted for five minutes, as before, and, after centrifugation, the 
upper l-chlorobutane layer was removed with a Pasteur pipette attached to an 
aspirator and discarded. To remove any 1-chlorobutane still present the 
remaining LON Hel was aerated for 1 minute by bubbling air through a 
Pasteur pipette into the sample. Hel was transferred to a conical centrifuge 
tube and, after addition of 20 pI concentrated NH40H, was extracted on a 
vortex mixer for one minute. After centrifugation for 2 minutes, the aqueous 
layer was discarded and a 3 pI of the organic layer was injected into the gas 
chromatography unit. 
3.4.2.2.2 One Step Extraction Method Using n-butyl Acetate 
Another liquid-liquid extraction method was tried in order to choose the 
best extraction method with good recoveries. The method tried used 
13 x 100 mm screw cap tubes, 1.0 ml of patient whole blood 'spiked' with the 
four drugs (Amitriptyline, Imipramine, Nortriptyline and Chlorpromazine) at a 
concentration 100 pg/ml which was combined with 1.0 ml of pH 11.0 
bicarbonate buffer and 300pl of n-butyl acetate. The tubes were capped and 
rotated for ten minutes. Next, the tubes were centrifuged at 3000 rpm for at 
least five minutes. After centrifugation, 100 pI at the upper organic layer was 
transferred to 6 x 50 mm tubes. Up to 2.0 pI of the solvent was injected into the 
gas chromatography system. 
- 112-
3.4.2.2.3 Liquid-Liquid Extraction with Hexane: Butan-I-ol 
Blood samples, 'spiked' with the four drugs (Amitriptyline, Imipramine, 
Nortriptyline and Chlorpromazine) at a concentration of 100 llglml, were used. 
1 ml of deionised water was added and the tubes were vortex mixed before 
addition of 1 ml 0.2M Na2C03. Tubes were again vortex mixed and 5 rnl of 
hexane: butan-1-o1 (95:5, v Iv) were added and the tubes gently agitated for 
thirty minutes. The samples were then centrifuged at 2500g for five minutes. 
The organiC layer was transferred to a clean set of extraction tubes containing 
l0011l of 0.2% phosphoric acid. These were gently agitated for thirty minutes 
and then centrifuged for five minutes. The organic layer was aspirated and the 
aqueous layer was discarded, 30 J..l.I of the organic layer was injected into the gas 
chromatographic system. 
3.4.2.2.4 Multistep Extraction Using Isoamyl Alcohol in n-Hexane 
In separate 16 - x 125 - mm. tubes, 1 rnl of blank blood 'spiked' with the 
four tricyclic drugs (Amitriptyline, Nortriptyline, Imipramine and 
Chlorpromazine at a concentration of l0011g/rnl) was combined with 200 pI of 
1M Na2C03, 200 III of the internal standard papaverine (500 llg/rnl) and 5 rnl 
of 2% (v Iv) isoamyl alcohol in n-hexane. The tubes were vortexed for thirty 
seconds and centrifuged at 3000 rpm for five minutes. The upper solvent layers 
were then transferred, using Pasteur pipettes, to clean screw-capped glass vials, 
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and 0.5 ml of O.5M HCl was added to each vial. The vials were vortexed for 
thirty seconds and centrifuged at intermediate speed for five minutes. The 
upper solvent layers were aspirated to waste and the aqueous layers were 
alkalinized by adding 0.5 ml of 1M Na2C03 to each vial. The final extraction 
was accomplished by injecting SOpl of 10% (v Iv) isoamyl in chloroform into 
each vial. The vials were vortexed for five minutes at an intermediate speed. 
The aqueous layer was discarded and an aliquot of the organic layer 
(30 pI) was injected into the gas chromatographic system. 
3.4.2.2.5 Single Extraction Procedure With Diethyl Ether 
Blood (1.0 ml) 'spiked' with the four drugs (Amitriptyline, Imipramine, 
Nortriptyline and Chlorpromazine all at a concentration of 100 pg/ml) was 
mixed with O.IM sodium hydroxide (0.5 ml) in a glass centrifuge tube. After 
addition of diethyl ether (3 ml) the tube contents were vortex mixed then 
centrifuged for five minutes at 3000 rpm. The organic phase was transferred 
into a second centrifuge tube containing 0.02SM hydrochloric acid (0.2 ml). 
This mixture was vortex mixed then centrifuged. The upper organic layer was 
aspirated and evaporated to dryness, while the aqueous layer was discarded. 
The residue was reconstituted with 50 JlI methanol containing the internal 
standard Papverine (500 Jlg/ml), 1 III was injected into the gas chromatography 
unit. 
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3.4.2.2.6 Extraction Using the Extracting Solvent Hexane:lsoarnyl Alcohol 
1 ml of blank blood 'spiked' with the four drugs of choice (Amitriptyline, 
Imipramine, Nortriptyline and Chlorpromazine all at a concentration or 
100 ~g/ml) was mixed with O.IM sodium hydroxide Na40H (0.2 ml) in a glass 
centrifuge tube. Two millilitres of hexane: isoamyl alcohol (99: 1 v Iv) was 
added and the sample was vortexed and centrifuged for 5 minutes at 4000 rpm. 
After centrifugation, the supernatant was transferred into a 3ml vial and then 
the solvent was evaporated under a stream of nitrogen at room temperature. 
The residue was reconstituted with 50 ~l methanol containing the internal 
standard papaverine (500 llg/ml) and 1111 was injected into the gas 
chromatography unit. 
3.4.2.2.7 Extraction With Ethylacetate 
2 ml of 'spiked' blood with each of the four drugs (Amitriptyline, 
Nortriptyline, Imipramine and Chlorpromazine at a concentration of 
100 llgl ml), 2 ml ethylacetate and 50 }.II of 10 M potassium hydroxide (KOH) 
were added to the 'spiked' blood sample. The tube containing the mixture was 
sealed, mixed on a rock-and-roll machine for ten minutes and centrifuged at 
3000 rpm. The supernatant (1 ml of the top acetate layer) was transferred to a 
clean 3 ml vial, and was evaporated to dryness under nitrogen. The residue 
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was reconstituted with methanol containing the internal standard Papaverine at 
a concentration of 0.5 mg/m!. 1 ~l was injected into the GC system. 
3.4.2.2.8 Reproducibility of the GC System: 
A standard solution of 3 ~g/ml of each of Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine was prepared in methanol. The 
reproducibility of the GC system was determined by injecting five injections of 
each of the standards each day, over three successive days, under the same 
conditions, to determine the day-to-day variation in retention times of the four 
drugs. The initial temperature was 120°C. The final temperature was 290°C. 
The initial time was two minutes. The final time was twelve minutes. He oven 
rise was BOC/minute. The injector temperature was 290°C. The detector 
temperature was 290°C. 
3.4.2.2.9 Minimum Detectability: 
Standard solutions of 1 )lg/ml of the four drugs (Amitriptyline, 
Nortriptyline, Imipramine and Chlorpromazine) was made up in methanol. A 
serial dilution of the four standard drug solutions in methanol was used to 
determine the minimum detectability of the four drugs on the GC system. 
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3.4.2.2.10 Reproducibility of the Extraction Method: 
Thirty samples of human post-mortem blood 'spiked' with the four 
tricyclic antidepressant drugs mixture (Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine in a concentration of 2 llg/ml) were liquid-
liquid extracted and analysed over three successive days. The peak height ratio 
of each drug against the internal standard (papaverine 500 llg/ml) was used to 
calculate the day-to-day variation of the extraction method of the four tricyclic 
antidepressants using the GC system. 
3.4.2.2.11 Calibration Curve 
The calibration curves for the four tricyclic drugs (Amitriptyline, 
Nortriptyline, Imipramine and Chlorpromazine) were constructed over the 
concentration range 0.5-10 ll/ml prepared in blank human post-mortem blood. 
Six samples at each concentration for each drug was liquid-liquid extracted as 
the method described earlier in 3.4.2.3.7. The samples were reconstituted with 
50 III methanol containing the internal standard papaverine (50 llg/ml). Ill1 
was injected into the GC system. The peak height ratios of drug over internal 
standard were plotted against concentration to construct a calibration curve for 
each tricyclic antidepressant drug. 
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3.4.2.3 Method of Extraction used in Stability Study 
3.4.2.3.1 In trod uction 
The method of extraction that was chosen after doing the studies to find 
out which method of extraction with good recoveries for the four drugs of 
choice for the stability study was the best. The best method was the liquid-
liquid extraction method using ethyl acetate and KOH, as explained 
previously. 
3.4.2.3.2 Materials 
3.4.2.3.2.1 Chemical and Reagents 
The chemicals and reagents were HPLC grade methanol. Ethyl acetate 
was used in extraction and 10 M KOH which was prepared by dissolving 56g of 
KOH in 100 ml distilled water. 
3.4.2.3.2.2 Internal Standard Solution Preparation 
The internal standard solution (papaverine) was prepared by dissolving 
it in a few drops of HPLC grade methanol until the drug is dissolved and 
making up to 100 ml with HPLC grade methanol, the resulting concentration 
being 500 pg / ml. 
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3.4.2.3.3 Drugs Extraction 
Two vials of each of the blood spiked samples (Amitriptyline, 
Nortriptyline, Imipramine and Chlorpromazine) and blank was removed from 
ib storage place, at each storage temperature (5, 25, -20° C), this was carried 
out each month between each analysis. The extraction was done by adding the 
samples each month at the three storage temperature, and extracted as in 
section 3.4.2.2.7. 
3.4.2.3.4 Drugs Analysis 
1 pI of reconstituted sample was injected into the gas chromatography 
unit. The GC conditions and the size of column used is described below. 
3.4.2.3.5 Equipment 
The separation of derivatized Amitriptyline, Nortriptyline, Imipramine 
and Chlorpromazine for all the analyses performed was achieved using 
Chrompack/Packard model 438A GC fitted with a capillary column 
(Chrompack CP-sil 5, 25m - x - 0.32 mm internal diameter with 0.4 urn film 
thickness). The injector temperature was 290°C. The initial oven temperature 
was 120°C. This was maintained for 2 minutes and then increased at 
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BOC/minute to 290°C. The final temperature was maintained for 12 minutes. 
The detectors were FlO /NPO detectors. 
Gas Flow Rate on the GC 
Helium was used as a carrier gas. The linear velocity was approximately 
60 cm/ sec through the column, achieved by maintaining a column head 
pressure at 5psi. 
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CHAPTER 4 - RESULTS AND DISCUSSION 
4.1 'SPIKED' SAMPLES, STORAGE, EXTRACTION AND 
ANALYSIS PROCEDURES 
The 'spiked' blood samples with the drugs under study was prepared at 
a concentration level consistent with toxicity in patients since most of the 
forensic toxicological cases involve measuring the drugs in samples following 
overdose. Therefore, when investigating the stability of the drugs of forensic 
interest in post-mortem blood)33,37-40] it is of importance to the toxicologist 
interpreting results that the study should be in accordance with the actual case. 
The storage temperatures were chosen to reflect laboratory practice. 
The SoC refrigeration represent the first storage temperature for samples 
received from the mortuary until a full drug screening is completed, usually 
days. Sometimes, as a result of further enquiries, weeks may pass between 
acquisition and drug quantitation. Then the samples must be kept at -20°C 
prior to analysis. The 2SoC represents the realistic temperature to which the 
corpse may have been exposed for a few days after death and as an upper 
limit for room temperature exposure. Therefore, it is important and 
necessary at the same time to ensure that the drugs are sufficiently stable at 
different storage temperatures and time intervals. The blood solutions of 
drugs were kept under the same storage conditions and then analysed at the 
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designated time. The concentrations of each drug in blood solution was 
analysed at the designated time. Freshly prepared drug standard samples 
were used to calculate the concentration of the drug in 'spiked' samples. In 
calculating the recovered drug the initial quantitation (day zero) was 
assigned a value of 100%. Successive quantitations were made and '% of 
original present' was calculated. The decrease in drugs concentration with 
time was obtained from the linear regreSSIOn curve constructed between 
concentrations (x) and the storage times (y). The linear regression was 
established for all drugs under study and at the three storage temperatures 
for blood samples. Figure 14 shows the procedure of storage, extraction and 
analysis of the specimen for drug stability. 
blood 
sampltS 
Jlortd 
ror (monlhs) 
Figure 14: 
Tricyclic Antidtpreu.nlJ 
The 'spiked' samples, storage, extraction and analysis procedure. 
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4.1.1 TEMPERATURE MONITORING OF 'SPIKED' SAMPLES 
Sample of whole blood were 'spiked' with benzodiazepines and tricyclic 
antidepressants and stored in a refrigerator (5°C), and incubator (25°C) and a 
deep freeze (-20°C). Storage temperatures were monitored regularly over 
24 hours throughout the course of the experiment which started after one 
month from spiking date (day zero) and ended at twelve months for both 
benzodiazepines and tricyclic antidepressants. 
Results and Discussion 
Figures 15, 16 and 17 demonstrate the fluctuation of the set storage 
temperatures 5, 25, -20°C monitored over different time intervals (hours, days, 
months). The average of each storage temperature over the different time 
intervals and the variation in temperatures over the different time intervals and 
the variation in temperature are summarised in Table 1. It shows there was a ± 
2.6% variation at 5°C, a ± 1.1% variation at 25°C and a ± 7% variation at -20°C 
over a 24 hours period. Over 7 days the fluctuation was a ± 2.8% at 5°C, a 
± 1.4% variation at 25°C and a ± 2.5% variation at -20°C. Over the 12 months 
there was a ± 3.4% variation at 5°C, a ± 1.1 % variation at 25°C and a ± 5.5% 
variation at -20°C. The measured temperatures are not significantly different 
from the set temperature at any given time throughout the course of the 
experiment. 
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Fluctuation of Storage Temperature 5°C Monitored Over: 
(a) Twenty-Four hours; (b) Seven days; (c) Twelve months. 
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Table 1: The Average Measured Temperature and Standard Deviation of the Three 
Storage Conditions Monitored Over Different Time Intervals (24 hours, 
7 d 12 th ) ays, mon s . 
Monitoring Refrigeration Incubator Deep Freeze 
Intervals Temperature Temperature Temperature 
set at SoC set at 2Soc set at -20°C 
24 hours 5.2 ± 0.13 26.1 ± 0.27 -20 ± 1.41 
7 days 5.1 ± 0.14 25.0 ± 0.35 -20 ± 0.5 
12 months 5.0 ± 0.17 25.1 ± 0.28 -19.8 ± 1.1 
Conclusions 
The temperature fluctuation of the three storage conditions are shown to 
be minimal and not significant, and within the normal temperature fluctuation 
range of refrigerators, incubators and freezers, with not more than O.5°C 
differences between set temperatures and actual temperatures of the three 
storage media. 
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4.2 RESULTS AND DISCUSSION OF SORBENT EXTRACTION 
4.2.1 CYANOPROPYL (CN) SORBENTS 
The absolute recoveries of the four benzodiazepine drugs (Triazolam, 
Temazepam, Desmethyldiazepam and Diazepam) from 'spiked' deionised 
water using the sorbent cyanopropyl (eN) were calculated by comparing the 
peak height ratio of the extracts from deionised water with unextracted 
standard solutions prepared in mobile phase at the same concentration and 
under identical conditions. 
Since cyanopropyl sorbent is a derivatised short propyl hydrocarbon 
chain placed near the surface of the silica, it will give the opportunity for the 
analyte to interact with the underlying silica through hydrogen bonding. In the 
case of benzodiazepines (weak bases) they will interact with the silica. 
Hydrogen bonding was the greatest in Temazepam and the lowest in 
Desmethyldiazepam. Elution of benzodiazepines from the cyanopropyl sorbent 
was facilitated with polar solvent that can disrupt the hydrogen bonding 
between functional groups on the analyte and the sorbent surface. Acidic 
methanol was more polar than 100% methanol which eluted the drug better. 
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Table 2 lists a recovery of above 88% for all benzodiazepine drugs using 
the acidic methanol eluent and low recoveries using the 100% methanol (less 
than 74%). 
Table 2: Percentage Recoveries of Benzodiazepine Drugs (0.9 J.lglml) from 'spiked' 
W CIS b ( 4) ater usmg .yanopropyl or ents n = 
Diazepam Temazepam Triazolam Desmethyl-
Diazepam 
Acidic Eluent 91 ± 5.2% 99 ± 2.2% 95 ± 3.1% 90 ± 3.8% 
Basic El uen t 69±2% 71 ± 2.9% 51 ± 2.8% 74 ±4.% 
Column: HypersIl5 11m C18 Cartridge (25 em x 4.6 mm i.d.) 
Mobile Phase: O.01M disodium hydrogen orthophosphate (pH 8.8):Methanol(30:70) 
Detection Wavelength: 230nm Flow Rate: 1 ml/minute 
Extracting whole post-mortem blood samples with benzodiazepine 
drugs using Bond Elut eN columns of 6 ml capacity using the same eluting 
solvent as for 'spiked' deionised water samples, gave low recoveries and sample 
to sample variation. 
4.2.2 BOND ELUT CERTIFY SORBENT 
The absolute recoveries of the four drugs (Diazepam, Temazepam, 
Triazolam and Desmethyldiazepam) from 'spiked' whole blood samples were 
calculated by comparing the peak height ratio of the extracts from whole blood 
with unextracted standard solutions prepared in mobile phase at the same 
concentration and under identical conditions. 
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The results of this study indicate that the developed procedure is an 
effective extraction method but it depends on the physical properties of the 
drugs and the eluting solvent used. Those drugs that have pKa close to the pH 
of the eluting system will give good recoveries. Clean extracts from whole 
blood were obtained. 
Table 3 shows the results of the four benzodiazepines obtained from 
'spiked' whole blood samples. 
Table 3: Recoveries of the Four Benzodiazepine Drugs Extracted from 'spiked' Whole 
Blood at a Concentration of 9 J.lWml using Bond Elut Certify Sorbent (n = 5). 
Drug Recovery (%) 
Diazepam 30.2% 
Desmethyldiazepam 39.6% 
Temazepam 74.2% 
Triazolam 78.3% 
Column: Hypersll5 rm C 18 Cartndge (25 cm x 4.6 mm i.d.) 
Mobile Phase: O.OIM disodium hydrogen orthophosphate (pH 8.8):Methanol(30:70) 
Detection Wavelength: 230nm Flow Rate: 1 ml/minute 
4.2.3 STRONG CAnON EXCHANGE (SCX) SORBENT 
Recoveries of the four benzodiazepine drugs (Diazepam, 
Desmethyldiazepam, Temazepam and Triazolam) were determined in 'spiked' 
whole blood samples by comparison of peak heights with unextracted 
standards and were determined over a concentration of 911g/rnl. 
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The method of sorption IS a mixed mode sorption isolation of 
benzodiazepines usmg a combination of reversed-phase C8 and cation 
exchange using a benzesulfonic acid cation exchange resin in hydrogen form. 
Applying the sample mixed with sodium phosphate buffer at pH 8.8, converts 
the resin into sodium form, and the pH 8.8 ionises the carboxyl group of 
benzodiazepines, thus, the drugs are sorbed in their ionic form by reversed-
phase, with sodium ion acting as a counter ion. Applying acetic acid displaces 
the cations present on cation exchange resin and converts the carboxyl anion to 
carboxylic acid, eluting the drugs with 2% ammoniated ethylacetate. 2% 
ammonium removes any protonated group and unlocks the ion exchange step 
of sorption and the ethylacetate elutes the drugs. 
The study was made of the absolute drug recoveries obtained by analysis 
after a concentration (evaporation and reconstitution) step. The recoveries for 
the four drugs were relatively good. 
The technique has advantages over liquid phase ion paired extraction in 
that it allows the removal of extraneous sample material by washing the 
support with an ionic solvent (phosphoric acid, acetic acid) to remove ionic 
material while the drugs are retained by nonpolar interaction with the benzene -
solufonyl-proply moiety. The final eluent (3% ammoniacal methanol) disrupts 
both ion unpaired and non-polar interactions and allows elution of all the drugs 
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in a relatively small volume. This washing results in the production of a cleaner 
extract. 
Table 4 shows the results of the extraction of four benzodiazepine drugs 
from 'spiked' blood sample using sex columns. 
Table 4: Absolute Recoveries (n = 4) of the Four Drugs Extracted from Whole 
Blood at a Concentration of 9 Jlglml. 
Drug Absolute Recovery (%) 
Diazepam 85.8% 
Desmethyldiazepam 88.6% 
Temazepam 86.9% 
Triazolam 84.1% 
Column: Hypersll 5 Jlm C 18 Cartndge (25 em x 4.6 mm i.d.) 
Mobile Phase: O.OIM disodium hydrogen orthophosphate (pH 8.8):Methanol(30:70) 
Detection Wavelength: 230nm Flow Rate: 1 ml/minute 
Mobile Phase for HPLC Use for Stability Study 
In reversed phase chromatography the mobile phases used are based on water 
mixed with different proportions of organic solvents, different proportions of 
mobile phases were tried for the analysis of benzodiazepines on HPLC system. 
The results are shown in Table 5. 
- 132 -
Table 5: Comparison of the Results of Different Mobile Phase Preparations 
K' 
Drugs (Capacity by Mobile Solvent 
Factor) Phase Ratios 
1 5.43 a.1M Na2HP04: Methanol 25:75 (v/v) 
2 4.93 pH 8.8 
3 3.92 
4 2.42 
1 5.63 a.1M mixture of 2 (O.53g+8.939) 
2 4.75 phosphate buffer pH5.4 in 1 litre water 
3 4.21 (disodium hydrogen 
4 2.60 
phosphate hexahydrate and 
potassium 
dihydrogenJPhosphate) 
(a) (b) Acetonitrile:phosphate a. 38:62 (v/v) 
1 6.32 5.43 buffer pH5.4 b. 70:30 (v/v) 
2 3.42 4.92 
3 3.75 3.62 
4 2.34 2.28 
1 8.42 a.1M Na2HP04.2H20 
2 7.63 pHIa.4 
3 4.9 
4 3.4 
1 3.29 Na2HP04·2H20: 80:100:8(v/v/v) 
2 2.75 Methanol: I-propanol 
3 1.83 
4 0.73 
1 9.47 Acetonitrile:Methanol: 30:35:35(v/v/v) 
2 8.62 water 
3 6.75 
4 5.38 
1 = Diazepam: 2 = Desmethyldiazepam: 3 = Temazepam: 4 = Triazolam 
4.2.4 BOND ELUT Cs SORBENT 
4.2.4.1 Recoveries 
The absolute recoveries of the four benzodiazepine drugs (Diazepam, 
Temazepam, Desmethyldiazepam and Triazolam) using Bond Elut C8 columns 
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of 3 ml capacity, containing Cs packing material were calculated by comparing 
peak height ratios of the extracted samples with unextracted standards 
prepared in mobile phase at the same concentration. 
The absolute recoveries of the four benzodiaLepine drugs are shown in 
Tables 6, 7, Sand 9. 
The recoveries for the four benzodiazepine drugs were considerably 
higher since benzodiazepine drugs are weakly basic compounds and they have 
the affinity to interact hydrophobically to the long C8 chain. The interaction 
was disrupted using chloroform as the eluting solvent. 
Table 6: The Recovery of Triazolam from 'spiked' Blood Extracted Through a Cs 
C I did b HPLC o umn an anatyse 'V 
Concentration (J.1g1mD Recovery (%) 
0.05 98 
0.2 96 
0.9 84 
2.0 92 
Column: Hypersil5 pm C18 Cartridge (25cm x 4.6 mm i.d.) 
Mobile Phase: acetonitrile:methanol:water (30:35:35 v Iv Iv) 
Detection Wavelength: 230nm Flow Rate: lml/minute 
Number of Samples 
6 
6 
6 
6 
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Table 7: The Recovery of Temazepam from 'spiked' Blood Extracted Through a C8 
C I d A I d b HPLC o umn an nalyse ,y 
Concentration (pglmD Recovery (%) 
0.05 84 
0.2 96 
0.9 86 
2.0 90 
Column: Hypersil5 11m CIS Cartridge (25cm x 4.6 mm i.d.) 
Mobile Phase: acetonitrile:methanol:water (30:35:35 v /v Iv) 
Detection Wavelength: 230nm Flow Rate: lml/minute 
Number of Samples 
6 
6 
6 
6 
Table 8: The Recovery of Desmethyldiazepam from 'spiked' Blood Extracted Through 
eel d A I d b HP C a -R 0 umn an nalyse ,y L 
Concentration (pglml) Recovery (%) 
0.05 84 
0.2 98 
0.9 93 
2.0 94 
Column: Hypersi15 11m CIS Cartridge (25cm x 4.6 mm i.d.) 
Mobile Phase: acetonitrile:methanol:water (30:35:35 v /v Iv) 
Detection Wavelength: 230nm Flow Rate: lmi/minute 
Number of Samples 
6 
6 
6 
6 
Table 9: The Recovery of Diazepam from 'spiked' Blood Extracted through a C8 
C I did b HPLC o umn an analyse )y 
Concentration (pglml) Recovery (%) 
0.05 94 
0.2 97 
0.9 94 
2.0 92 
Column: Hypersil5 11m CIS Cartridge (25cm x 4.6 mm i.d.) 
Mobile Phase: acetonitrile:methanol:water (30:35:35 v /v Iv) 
Detection Wavelength: 230nm Flow Rate: lmi/minute 
Number of Samples 
6 
6 
6 
6 
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4.2.5 CALIBRA nON CURVES 
The calibration curves for the four benzodiazepine drugs (Triazolam, 
Temazepam, Desmethyldiazepam and Diazepam) were drawn over the 
concentration range 0.05 - 2 ]lg/ml prepared in blank blood. Six samples of 
each concentration for each drug were extracted through Bond Elut C8 
columns. The internal standard (Prazepam) was added to all samples. The 
peak height ratios of drug over internal standard at each concentration was 
plotted to construct a calibration curve for each benzodiazepine drug. A 
standard calibration curve was constructed using the peak height ratios 
(std/I.std) and the benzodiazepine drug concentrations. The relation between 
benzodiazepine drugs (Diazepam, Desmethyldiazepam, Temazepam, 
Triazolam) concentration and average peak height ratio (std I.std) of samples 
analysed by HPLC are highlighted in Table 10. 
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Table 10 St t' t' lOt f th F C l'b r C a IS lea a a or e our a I ra Ion urves 0 fB d' enzo lazeplnes 
Concen tra tion A verage Peak 
Drug (J.lglml) Height Ratio 
n=6 
Diazepam 0.05 0.02 
0.2 0.25 
0.9 1.3 
2.0 2.4 
Desmethyldiazepam 0.05 0.028 
0.2 0.29 
0.9 1.2 
2.0 2.4 
Temazepam 0.05 0.048 
0.2 0.24 
0.9 1.2 
2.0 2.1 
Triazolam 0.05 0.04 
0.2 0.23 
0.9 1.33 
2.0 2.8 
Column: HypersIl5 ~m C18 CartrIdge (25 cm x 4.6 mm l.d.) 
Mobile Phase: O.OIM disodium hydrogen orthophosphate (pH 8.8):Methanol(30:70) 
Detection Wavelength: 230nm Flow Rate: 1 ml/minute 
The equations of the lines are: 
y = 1.19 x +0.04, y = 1.17 x +0.04, y = 1.04 x +0.07, y = 1.40 x +0.02 
for the Diazepam, Desmethyldiazepam, Temazepam and Triazolam, 
respectively, and the regressions are: 
0.9966, 0.9977, 0.9988 and 0.9999 for Diazepam, Desmethyldiazepam, 
Temazepam and Triazolam, respectively. 
A linear relation was obtained for each drug as shown in Figures 18, 19,20 and 
21. A 50 pg/ml of benzodiazepine drug extracted solution chromatogram at 
range 0.02 is shown in Figure 22. 
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Figure 18: Calibration Curve of Diazepam 
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Figure 19: Calibration Curve of Deamethyldiazepam 
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4.2.6 THE REPRODUCIBILITY OF THE EXTRACTION METHOD 
Thirty samples of human blood 'spiked' with the four benzodiazepine 
drugs mixture (Triazolam, Temazepam, Desmethyldiazepam and Diazepam) in 
a concentration of O.911g/ml of blood were extracted through Bond Elut C8 
column of 3 m1 capacity and analysed over three successive days. The peak 
height of each drug was used to calculate the day to day variation of the 
extraction and analysis method of the four benzodiazepines using HPLC 
system. 
Table 11 shows the average recoveries, co-efficient of variation and 
number of samples used each time. Excellent recoveries were obtained for the 
four benzodiazepine drugs. The recovery was calculated by comparing the 
peak height of unextracted standard benzodiazepine drugs with extracted 
samples. 
4.2.7 REPRODUCIBILITY OF THE HPLC SYSTEM 
The reproducibility of the HPLC system for the four benzodiazepine 
drugs (Diazepam, Temazepam, Desmethyldiazepam, Triazolam) was tested 
over three days. A summary of the reproducibility of the four benzodiazepine 
drugs is summarised in Table 12. 
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Table 11: Reproducibility of Recovery of Benzodiazepine Drug over a 3 day period 
C I f usmg -R co umns or extrachon. 
Drug Days Average 
Recoveries 
Diazepam 1 93 
2 93 
3 93 
Desmethyl- 1 92 
Diazepam 2 92 
3 91 
Temazepam 1 88 
2 88 
3 87 
Triazolam 1 87 
2 87 
3 87 
Column: Hypersil5].lm CI8 Cartridge (25cm x 4.6 mm i.d.) 
Mobile Phase: acetonitrile:methanol:water (30:35:35 v Iv Iv) 
Coefficient 
Variation 
1.10% 
0.98% 
1.30% 
1.02% 
0.98% 
0.89% 
0.88% 
0.88% 
1.20% 
0.89% 
0.89% 
0.88% 
Detection Wavelength: 230nm Flow Rate: Iml/minute 
No of Samples 
Extracted 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
Ta b I ble 12: The Reproduci i ity 0 f h t e Four Benzodiazepine Drugs by HPLC 
Within Day Variation Day-to-Day Variation 
COV COV over three days 
(6 samples analysed) (24 samples analysed) 
Diazepam 2.2% 2.9% 
Desmethyldiazepam 1.4% 2.3% 
Temazepam 3.3% 3.9% 
Triazolarn 1.6% 2.1% 
Column: Hypersil5].lm C18 Cartridge (25cm x 4.6 mm i.d.) 
Mobile Phase: acetonitrile:methanol:water (30:35:35 v Iv Iv) 
Detection Wavelength: 230nm Flow Rate: Iml/minute 
4.2.8 DRUG EXTRACTION 'SPIKED' SAMPLES 
Samples of whole blood 'spiked' with drugs were extracted and analysed 
at designated time. In each analysis a standard and blank were prepared to 
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calculate the concentration of drugs under study. Data of each study were 
accumulated and tabulated at the end of the experiment. 
The decline in drug concentrations were represented here by xy curve 
where x represents the drug concentration and y represents the storage time. 
From the curves presented it will be noticed that the drug concentration 
decreases at six months then increases the following month. This could be 
explained by the drug being bound with blood protein and therefore a decrease 
in drug concentration would be expected. When the drugs were released from 
the protein a higher concentration would be expected. 
The standard for significant breakdown of drug to have occurred was a 
level measured which ranged between 0.45 - 5.5 SD from day zero concentration. 
4.2.8.1 Benzodiazepines 
4.2.8.1.1 Diazepam Stability 
Diazepam concentration in blood solution samples at the three different 
storage temperatures and time periods are summarised in Table 13. The 
percentage standard deviation for blood Diazepam for the entire method of 
extraction and analysis was 6.7% 
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Table 13: The Concentration of Diazepam (Jlglml) in Blood Solution Stored at 5, 25 and -20 
o C d & h egrees enhgra e om Day Zero up to 12 mont s. 
Concentration Concentration Concentration 
Storage When Stored When Stored When Stored 
at 25°C at 5°C at -20°C 
Zero Day 5.0 5.0 5.0 
1 month 4.8 4.7 5.0 
2 months 4.6 4.8 4.8 
3 months 4.9 5.9 4.8 
4 months 4.6 4.8 4.7 
5 months 4.7 4.6 4.7 
6 months 4.7 4.8 4.8 
7 months 4.9 3.9 4.6 
8 months 3.8 4.2 4.6 
9 months 3.4 4.9 4.8 
10 months 3.0 3.5 3.9 
11 months 2.8 3.2 3.8 
12 months 2.7 2.9 3.4 
The decline in blood Diazepam concentration at 25°C was low until the 
seventh month of storage. At the eighth month the decrease in blood Diazepam 
concentration in samples stored at 24°C was significant, with a recovery of 76%. 
After twelve months of storage, the recovery was 54% at the storage 
temperature 25°C. 
The blood Diazepam concentration was relatively stable up to nine 
months of storage at the storage temperature 5°C and -20°C, the recoveries of 
drug being 80% and 96%, respectively. After twelve months of storage, more 
than 50% of the drug could be recovered. 
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An average decrease in concentration of 200 ng/ml was observed at up 
to six months of storage regardless of storage temperature. An average 
decrease in concentration of 400 ng/ml was observed from the seventh up to 
twelve months at the storage temperature 25°C. A 900 ng/ml decrease in 
concentration was observed for drug Diazepam samples stored at 5°C after 
seven months of storage. At eight months the concentration rises to 500 ng/ml 
from previous months and at nine months rises to 700 ng/ml from the eighth 
month. Eventually it drops again to reach 2100 ng/ml of the original 
concentration. At -20°C after six months of storage the decrease was uniform. 
200 ng/ml at up to eight months then drops to reach 1600 ng/ml of the original 
concentration. 
From the above findings, Diazepam was shown to follow the same 
pattern of decrease in concentration regardless of the storage temperature or the 
storage media and a reasonable amount of Diazepam would be recovered even 
after twelve months of storage. 
A comparison between blood Diazepam samples stored at the three 
storage temperatures is shown in Figure 23. 
Figure 24 shows the chromatogram of Diazepam after six months 
storage at 25°C. 
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Figure 23: Changes in Diazepam Concentration with Time in Blood Samples Stored at 25, 5 and -20 Degrees Centigrade from 
Day Zero up to 12 months. 
Figure 24: 
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10 5 
Chromatogram of Diazepam at 25°C after 6 months of Storage 
By HPLC system 
Range: 0.32 
RT of Diazepam: 10.6 
Injection 
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4.2.8.1.2 Desmethyldiazepam Stability 
The results of blood solution 'spiked' with Desmethyldiazepam stored at 
the three different storage temperatures and analysed at the designated times 
are summarised in Table 14. The percentage standard deviation of the 
Desmethyldiazepam was 5.3% of blood Desmethyldiazepam for the entire 
experiment. 
Table 14: The Concentration of Desmethyldiazepam (JlglmD in Blood Solution Stored at 5, 
25 d 20 D C f d fr D Z t 12 th an - egrees en 19ra e om ay eroup 0 mon s. 
Concentration Concen tration Concentration 
Storage When Stored When Stored When Stored 
at 2SoC at SOC at -20°C 
Zero Day 3.0 3.0 3.0 
1 month 2.6 2.7 2.8 
2 months 2.1 2.4 2.9 
3 months 2.1 2.5 2.7 
4 months 1.9 2.1 2.6 
5 months 1.7 1.9 2.7 
6 months 1.9 1.9 2.5 
7 months 1.5 2.0 2.2 
8 months 1.1 1.7 2.4 
9 months 1.3 1.8 2.1 
10 months 0.9 1.6 1.8 
11 months 0.6 1.3 1.6 
12 months 0.9 1.4 1.7 
Figure 25 shows the decline in concentration for blood samples stored at 
5°C, 25°C and -20°C for Desmethyldiazepam. A significant decline in blood 
concentration was observed for those samples stored at 25°C. After six months 
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of storage 63% of the drug could be recovered from the samples stored at 25°C. 
After twelve months of storage 30% of the drug could be recovered. Only 46% 
of the Desmethyldiazepam was recovered after twelve months of storage, while 
for those samples stored at -20°C, up to 83% of the drug could be recovered 
after six months of storage, and after twelve months of storage 57% of the 
Desmethyldiazepam could be recovered. 
At 25°C, after two months of storage, a decrease of 500 ng/ml was 
observed on the concentration of Desmethyldiazepam. At up to six months of 
storage the decrease was steady at 200 ng/ml in concentration, and after six 
months the decrease was also steady but higher, an average of 400 ng/ml in 
concentration. At 5°C an average decrease of 300 ng/ml was observed up to six 
months. The decrease was 600 ng/ ml between the seventh and the twelfth 
months. A decrease of 500 ng/ml was observed between day zero and the sixth 
month at -20°C. The decrease was noticed to be steady between the sixth and 
the twelfth months, the average decrease being 300 ng/ml. 
Figure 26 shows the decrease in blood Desmethyldiazepam concentration 
at 5°C after twelve months of storage. 
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Figure 25: Changes in Desmethyldiazepam Concentration with Time in Blood Samples Stored at 25, 5 and -20 Degrees 
Centigrade from Day Zero up to U months. 
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Injection 
10 
5 
Figure 26: Chromatogram of Desmethyldiazepam at SOC after 12 months 
Of Storage by HPLC System 
Range: 0.04 
RT of Desmethyldiazepam: 7.8 
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Conclusion 
Desmethyldiazepam showed the best stability for those samples at -20°C. 
After one year of storage the drugs can still be detected at a storage temperature 
of -20°C. A significant decrease in Desmethyldiazepam concentration was 
observed for samples stored at both 25°C and 5°C temperatures, with the 
greater and more rapid decrease occurring in the blood stored at room 
tempera ture. 
4.2.8.1.3 Temazepam Stability 
The stability of Temazepam in blood was investigated. 'Spiked'samples 
of blood with Temazepam, at a concentration of 5.0 llg/ml from day zero until 
twelve months, was studied. 
The results of the blood solution 'spiked' with Temazepam stored at the 
three storage temperatures were analysed at the designated times and are 
presented in Table 15. 
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Table 15: The Concentration of Temazepam (llg/ml) in Blood Solution Stored at 5, 25 and -
20Deg ees C d fr omDa enhgra e Zero up to 12 months. 
Concentration Concentration Concentration 
Storage When Stored When Stored When Stored 
at 2SoC at SoC at -20°C 
Zero Day 5.0 5.0 5.0 
1 month 4.9 4.8 5.0 
2 months 4.6 4.5 4.8 
3 months 4.4 4.4 4.8 
4 months 4.2 4.5 4.8 
5 months 4.2 4.6 4.7 
6 months 4.4 4.5 4.4 
7 months 4.1 4.4 4.6 
8 months 4.2 3.9 4.2 
9 months 3.7 3.8 4.2 
10 months 3.4 3.6 3.8 
11 months 3.1 3.4 3.5 
12 months 2.8 3.1 3.5 
The percentage standard deviation for the entire Temazepam analysis at 
the three temperatures was 5.7%. The standard for significant breakdown of 
Temazepam to have occurred was a level measured which had decreased by 
±0.57 from day zero concentration. 
Figure 27 shows the decline in Temazepam concentration from day zero 
up to twelve months when stored at the three different temperatures (5°C, 25°C 
and -20°C). Samples of blood stored at 25°C declined steadily. At twelve 
months 56% of the drug could still be detected. For the samples that were 
refrigerated at SoC, at six months 90% ±2 of the drug could be detected, the same 
as for those samples stored at -20°C for the same time. For those samples stored 
up to twelve months at 5°C, 2SoC and -20°C, the recovery was 62%±8. 
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An average decrease in concentration at 200 ng/ml was observed at up 
to six month of storage regardless of the storage temperature. A decrease of 500 
ng/ml was observed between the eighth and the ninth months of storage. Then 
a steady decrease of an average of 300 ng/ml was observed at up to a year for 
the samples stored at 25°C. At 5°C the decrease was high between the seventh 
and eighth month, 500 ng/ ml in concentration. Afterwards the decrease was 
steady, an average of 200 ng/ml in concentration at up to twelve months. At-
20°C the decrease was steady after six months of storage, an average of 400 
ng/ml in concentration. 
A chromatogram showing the decrease in blood Temazepam 
concentration after 8 months at -20°C is shown in Figure 28. 
An average decrease in concentration of 2000 ng/ml was observed for 
the samples stored at 25°C and -20°C, while at 5°C the average decrease in 
concentration was less at 1000 ng/ml. After the sixth month the decrease was 
steady. The decrease in concentration was an average of 2000 ng/ml at up to 
the twelfth month for the samples stored at 25°C and -20°C and 3000 ng/ml in 
concentration of the samples stored at 5°C. 
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5 
Chromatogram of Temazepam at -20°C after 8 months of 
Storage by HPLC System. 
Range: 0.32 
RT of Temazepam: 7.4 
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Conclusion 
Blood Temazepam is stable when stored at 5°C and -20°C. It could be 
detected up to a year when stored at any temperature, being able to have 56% 
recovery when stored at room temperature. 
4.2.8.1.4 Triazolam Stability: 
The results of the blood solution 'spiked' with Triazolam stored at three 
storage temperatures and analysed at designated times are summarised in Table 
16. The percent standard deviation of the Triazolam was 5.1% for blood 
Triazolam for the entire experiment. 
Table 16: The Concentration of Triazolam (JIglml) in Blood Solution Stored at 5, 25 and -20 
Degrees C d fro D Z 12 th entigra e m ay eroup to mon s. 
Concentration Concentration Concentration 
Storage When Stored When Stored When Stored 
at 2SoC at SoC at -20°C 
Zero Day 50 50 50 
1 month 47 48 48 
2 months 46 47 49 
3 months 47 47 48 
4 months 45 45 48 
5 months 47 46 49 
6 months 45 45 47 
7 months 44 46 48 
8 months 40 44 46 
9 months 38 38 46 
10 months 36 36 44 
11 months 34 34 44 
12 months 32 31 42 
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Figure 29 shows the decline in Triazolam concentration in blood samples 
stored at soc, 2SOC and -20°C. 
In concentration an average decrease of 2000 ng/ml was observed for the 
samples stored at 2SoC and -20°C, while at SoC the average decrease in 
concentration was less (1000 ng/ml). After the sixth month the decrease was 
steady, the decrease in concentration was an average of 2000 ng/ml up to the 
twelfth month for the samples stored at 2SoC and -20°C and 3000 ng/ml in 
concentration for the samples stored at soc. 
A steady decrease in Triazolam concentration is shown at the three 
different storage temperature. Up to six months the percentage of recovery of 
Triazolam was 94% for drugs stored at -20°C and 90% for those stored at 5 and 
25°C. After one year 65% was recovered of Triazolam blood at 25°C, 74% for 
the blood sample stored at 5°C and 84% of the blood samples stored at -20°C. A 
chromatogram showing the decrease in Triazolam concentration after 4 months 
of storage at 2SoC is shown in Figure 30. 
Conclusion 
Triazolam showed the best stability over the other benzodiazepines 
studied since blood solution at the three storage temperatures showed average 
recoveries 91 % ±3 for blood after six months of recovery. After one year of 
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storage about 74% ±1O of Triazolam was recovered regardless of the storage 
temperature in blood. 
Figure 30: shows the change in concentration of Triazolam drug after four 
months of storage. 
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Injection 
10 5 
Chromatogram of Triazolam at 25°C after 4 months of Storage 
Analysed by HPLC System 
Range: 0.32 
RT of Triazolam 7.0 
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4.4 RESULTS AND DISCUSSION OF LIQUID-LIQUID 
EXTRACTION 
4.4.1 SAMPLE EXTRACTION USING 1-CHLOROBUTANE 
This method has an advantage over other methods in that with the 
extraction step using l-chlorobutane as the extracting solvent with gas 
chromatographic analysis, the complete analysis can be accomplished in one to 
one-half hours. 
Most solvents in use for drug extraction also extract interfering 
substances, making phase separation and evaporation difficult by this 
procedure by using 1-chlorobutane as an extracting solvent eliminated the time-
consuming steps of evaporation. 
Recoveries of the four tricyclic antidepressants (Amitriptyline, 
Nortriptyline, Imipramine and Chlorpromazine) were determined in 'spiked' 
whole blood samples by comparison of peak height ratio of the extracts with 
unextracted standards and were determined over a concentration of 100 llg/ml, 
shown in Table 17. 
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Table 17: Retention Times and Recoveries of Tricyclic Drugs (100 pg/ml) for 'spiked' 
Blood. 
Drug Retention Time % Recovery (minutes) 
Amitriptyline 14.7 69.2 
Nortriptyline 13.2 59.8 
Imipramine 14.9 79.8 
Chlorpromazine 18.1 56.9 
Column: Chrompack CP-stl5, 25 m x 0.32 mm i.d.O.4 J.1m film thickness 
Oven Temperature: Initial temp. 120°C Final temp. 290°C FID/NPD detector 
4.4.2 ONE STEP EXTRACTION METHOD USING N-BUTYLACETATE 
The absolute recoveries of the four drugs (Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine) from 'spiked' whole blood samples were 
calculated by comparing the peak height ratio of the extracts from whole blood 
with unextracted standard solutions at the same concentration and under 
identical conditions. The percentage recovery for each drug and its retention 
time is shown in Table 18. 
Table 18: The Absolute Retention Time and Drug Recoveries of the Four Extracted 
Drugs at a Concentration of 100 J.1Wml. 
Drug Absolute Retention % Recovery 
Time (RT) min. 
Ami triptyline 15.16 73 
Nortriptyline 15.83 75 
Imipramine 15.62 77 
Chlorpromazine 18.83 65 
Column: Chrompack CP-sI15, 25 m x 0.32 mm l.d.O.4 J.1m film thickness 
Oven Temperature: Initial temp. 120°C Final temp. 290°C FID/NPD detector 
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This procedure has been highly successful with whole blood because it 
exhibits less emulsification and relatively good recoveries for the four drugs. 
The success of the described extraction is that it meets the requirement of 
today's toxicology laboratory, that is, small sample volume, short analysis time, 
ease of sample preparation and sensitive detection. This procedure has 
replaced a more time consuming multi-step extraction procedure that required 
evaporation and reconstitution. Butylacetate was chosen as the solvent in this 
procedure for its lack of volatility and its polarity, which is essential in a single-
step extraction without evaporation. 
4.4.3 LIQUID-LIQUID EXTRACTION WITH HEXANE: BVTAN-I-OL 
Extraction recoveries of the four tricyclic antidepressant drugs 
(Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine) was 
determined by comparing the peak heights of extracted blood with peak heights 
of the standard papaverine prepared in methanol at the same concentration and 
under identical conditions. 
The method provides an advantage over previously reported methods by 
allowing quantitation of antidepressants in a single extraction. 
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Clean extracts were obtained from extracting the blood samples but 
could not guarantee the absence of interferences. 
The absolute recoveries of the four drugs are shown in Table 19. 
Table 19: Percentage Average Recoveries (n = 4) of Tricyclic Drugs (100 Jlg/ml) from 
Blood. 
DruQ:s % Average 
Recoveries 
Amitriptyline 85.5 
Nortriptyline 74.3 
Imipramine 84.0 
Chlorpromazine 70.0 
Column: Chrompack CP-sII5, 25 m x 0.32 mm Ld.O.4 ).lm fIlm thIckness 
Oven Temperature: Initial temp. 120°C Final temp. 290°C FID/NPD detector 
The highest recovery was for the drug Amitriptyline and the lowest was 
for Chlorpromazine. 
4.4.4 MULTI-STEP EXTRACfION USING ISOAMYL ALCOHOL IN N-HEXANE 
The major advantage of this method for tricyclic antidepressant extraction 
from blood is the low volume of sample used. The described extraction procedure 
requires only 1 ml of blood. The procedure is clean, sensitive, reliable, rapid and 
inexpensive. 
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The resulting extracts, when analysed usmg capillary columns with 
nitrogen-selective, yielded valuable qualitative data. 
The absolute recoveries of the four tricyclic drug (Amitriptyline, 
Nortriptyline, Imipramine and Chlorpromazine) from 'spiked' blood were 
calculated by comparing the peak height ratio of the extract with unextracted 
standard solution under identical conditions and are shown in Table 20. 
Table 20: Percentage Average Recoveries (n = 4) for the Four 
Tricyclic Antidepressants (100 Jlg/ml) 
Drug % Average 
Recoveries 
Amitriptyline 60.8 
Nortriptyline 64.3 
Imipramine 60.3 
Chlorpromazine 58 
Column: Chrompack CP-sIl5, 25 m x 0.32 mm l.d.O.4 J.lm hlm thIckness 
Oven Temperature: Initial temp. 120°C Final temp. 290°C FID/NPD detector 
The recoveries of the four drugs ranged from a high of 64.3% for 
Nortriptyline to a low of 58% for Chlorpromazine. 
4.4.5 SINGLE EXTRACTION PROCEDURE WITH DIETHYLETHER 
This procedure is a successful method of extraction due to the small initial 
volume of blood taken (1 ml). It is a convenient, simple and relatively rapid 
method of extraction. 
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Extraction with diethylether gave a cleaner extract than did other solvents. 
The direct injection of an organic aliquot from such an extraction gave good peak 
shapes of the compounds when analysed. 
The absolute recoveries of the four drugs (Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine) from 'spiked' blood were calculated by 
comparing the peak height ratio of the extract with the unextracted standard 
solution under identical conditions. The results are shown in Table 21. 
Table 21: Percentage Average Recoveries (n = 4) for the Four 
Tricyclic Antidepressant Drugs (100 Jlg/ml) 
Drug % Average 
Recoveries 
Ami triptyline 56.5 
Nortriptyline 61.8 
Imipramine 54.3 
Chlorpromazine 53.5 
Column: Chrompack CP-sil5, 25 m x 0.32 mm Ld.0.4 pm film thickness 
Oven Temperature: Initial temp. 120°C Final temp. 290°C FID/NPD detector 
The average recoveries of the drugs ranged between 53.5 - 61.8% which is 
considered to be low. 
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4.4.6 LIQUID-LIQUID EXTRACTION USING THE EXTRACTING SOLVENT 
HEXANE: ISOAMYL ALCOHOL 
This procedure was an efficient one In terms of the low number of 
procedural stages in achieving the extraction. 
Samples high in lipid often emulsify during liquid-liquid extraction. This is 
especially true with a solvent such as hexane. The addition of isoamyl alcohol 
increases the polarity of hexane which inhibits emulsion formation and minimises 
adsorption of tricyclic antidepressants onto the surface of the glassware. 
With all the advantages that this procedure has, still the percentage 
recoveries were not high. 
The absolute recoveries of the four tricyclic antidepressant drugs 
(Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine) from 'spiked' 
blood were calculated by comparing the peak height ratio of the extracts from 
blood with the unextracted standard solution under identical conditions. These are 
shown in Table 22. 
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Table 22: Percentage Average Recoveries of Tricyclic Antidepressant Drugs (100 ).lglml) 
f "k d' BI d rom Spl e 00 
Drug % Average 
Recoveries 
Amitriptyline 59.5 
Nortriptyline 61 
Imipramine 55.3 
Chlorpromazine 50.5 
Column: Chrompack CP-si15, 25 m x 0.32 mm i.d.O.4 ~m film thickness 
Oven Temperature: Initial temp. 120°C Final temp. 290°C FID/NPD detector 
4.4.7 LIQUID-LIQUID EXTRACTION WITH ETHYLACETATE 
This method was chosen for its good recoveries for the four drugs 
(Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine) from 'spiked' 
blood samples over a concentration range of 2.5 - 50pg/rnl. 
The absolute recoveries of the four TCA drugs were calculated by 
comparing peak height ratios of the extracted samples with the unextracted 
standards under identical condition. 
The recovery of Amitriptyline was from 'spiked' blood using liquid-
liquid extraction and analysed by GC (Table 23). 
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Table 23: Recovery of Amitriptyline from 'spiked' Blood by Liquid-Liquid Extraction 
an d A I db GC nalyse )y 
Concentration (J.lglml) Recovery (%) Number of Samples 
2.5 78.4 ± 4.0% 4 
5.0 86 ± 2.5% 4 
10 95 ± 3.0% 4 
50 106 ± 6.0% 4 
The recovery of Nortriptyline was from 'spiked' blood using liquid-liquid 
extraction and analysed by GC (Table 24). 
Table 24: Recovery of Nortriptyline from 'spiked' Blood by Liquid-Liquid Extraction 
an d A I db GC nalyse )y 
Concentration (J.lglmU Recovery (%) Number of Samples 
2.5 72.6 ± 3.0% 4 
5.0 84 ± 3.5% 4 
10 92 ±4.0% 4 
50 108 ± 4.5% 4 ~ 
The recovery of Imipramine was from 'spiked' blood using liquid-liquid 
extraction and analysed by GC (Table 25). 
Table 25: Recovery of Imipramine from 'spiked' Blood by Liquid-Liquid Extraction 
an d A I db GC nalyse 'Y 
Concentration (J.lglmU Recovery (%) Number of Samples 
2.5 73 ± 2.0% 4 
5.0 84 ± 3.0% 4 
10 93.5 ± 3.0% 4 
50 102 ± 5.0% 4 
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The recovery of Chlorpromazine from 'spiked' blood using liquid-liquid 
extraction and analysed by GC (Table 26). 
Table 26 Recovery of Chlorpromazine from 'spiked' Blood by Liquid-Liquid 
E d A I db GC xtrachon an nalyse ,y 
Concentration (pglmD Recovery (%) Number of Samples 
2.5 71.2 ± 3.0% 4 
5.0 80.7 ± 2.5% 4 
10 90.5 ± 3.0% 4 
50 104 ± 4.5% 4 
4.4.8 THE REPRODUCIBILITY OF THE EXTRACTION METHODS 
Thirty samples of human post-mortem blood 'spiked' with the four 
tricyclic antidepressant drugs mixture (Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine) in a concentration of 2 pg/ml were liquid-
liquid extracted and analysed over three successive days. The peak height of 
each drug was used to calculate the day to day variation of the extraction and 
analysis method of the four tricyclic antidepressants using GC systems. 
Table 27 shows the average recoveries, co-efficient of variation and 
number of samples used each time. Good recoveries were obtained but were 
not very high at a concentration of 2 pg/ml but is shows that the method was 
reproducible. The recovery was calculated by comparing the peak height ratio 
of the unextracted standard tricyclic antidepressants with extracted samples. 
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Table 27: Reproducibility of Recovery of Tricyclic Antidepressant Drugs over a 3 Day 
P . d . L' 'd L' 'd E eno usmg lqUI 
- lqUl xtrachon. 
Drug Days Average Coefficient Noof Recoveries Variation Samples 
% Extracted 
Ami tri p ty line 1 81.3 1.2 10 
2 81.7 1.51 10 
3 81.5 1.51 10 
Nortriptyline 1 75.6 1.2 10 
2 75.7 1.1 10 
3 75.5 0.660 10 
Imipramine 1 75.9 1.4 10 
2 75.4 0.74 10 
3 75.5 0.97 10 
Chlorpromazine 1 72.2 1.4 10 
2 72.9 1.6 10 
3 73 1.2 10 
4.4.9 REPRODUCIBILITY OF THE GC SYSTEM 
The reproducibility of the GC system for the four tricyclic antidepressant 
drugs (Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine) was 
tested over three days. A summary of the reproducibility for the four TCA 
drugs is shown in Table 28. 
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Table 28: Reproducibility of the GC System for the Analysis 
f h FT' r'd D o t e our rIC C IC Anh epressant rugs 
Within Dav Variation COY Day-to-Day Variation COY 
(6 samples analysed) over three days 
(24 samples analysed) 
Amitriptyline 4.2% 4.9% 
Nortriptyline 3.9% 3.5% 
Imipramine 2.3% 3.4% 
Chlorpromazine 2.5% 3.2% 
Column: Chrompack CP-sI15, 25 m x 0.32 mm J.d.O.4]..lm film thickness 
Oven Temperature: Initial temp. 120°C Final temp. 290°C FlD/NPD detector 
4.4.10 CALI BRA nON CURVES 
The calibration curves for the four tricyclic antidepressant drugs 
(Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine) were 
constructed over the concentration range 0.5 - 10 llg/ml prepared in blank 
blood. Six samples at each concentration were liquid-liquid extracted. The 
internal standard papaverine was added to all samples. The peak height ratios 
of drugs over the internal standard at each concentration were plotted to 
construct a calibration curve for each tricyclic antidepressant drug. The 
relationship between the tricyclic antidepressant drugs (Amitriptyline, 
Nortriptyline, Imipramine and Chlorpromazine), concentration and average 
peak height ratio (std/I.std) of samples analysed by GC are highlighted in 
Table 29. 
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Table 29: Statistical Data for the Four Calibration Curves of Tricyclic Antidepressants 
Drug Concentration 
A verage Peak Height 
(pglmD Ratio 
On=6 
Amitriptyline 0.5 1.0 
2.0 3.7 
4.9 6.1 
8.0 14.1 
10.0 17.1 
Nortriptyline 0.5 1.1 
2.0 4.0 
4.0 7.1 
8.0 13.8 
10.0 18.0 
Imipramine 0.5 1.2 
2.0 3.8 
4.0 6.6 
8.0 13.8 
10.0 18.1 
Chlorpromazine 0.5 1.4 
2.0 4.2 
4.0 6.8 
8.0 14.4 
10.0 17.2 
A linear relation was obtained for each drug as shown in Figures 31, 32, 
33 and 34. 
The equations of the lines were: 
y = 1.72 x +0.03, y = 1.74 x +0.27, y = 1.76 x +0.07, y = 1.68 x +0.57 
for Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine, 
respectively, and the regressions were: 
0.9991, 0.9970, 0.9982 and 0.9981 for Amitriptyline, Nortriptyline, 
Imipramine and Chlorpromazine, respectively. 
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4.4.11 DRUG EXTRACTION OF 'SPIKED' SAMPLES WITH TRICYCLIC ANTIDEPRESSANTS 
Sample~ L)f whole blood 'spiked' with the antidepressant drugs were 
extracted and analysed at the designated times. In each analysis a standard and 
blank were prepared to calculate the concentration of drugs. The data of each 
study were accumulated and tabulated at the end of the experiment. 
The standard for significant breakdown of tricyclic antidepressant drugs 
to have occurred was a level measured which ranged between 0.62 - 2.8 from 
day zero concentration. 
4.4.11.1 Amitriptyline Stability 
Amitriptyline concentration in blood samples at the three different 
storage temperatures and time period are summarised in Table 30. 
The decline in blood Amitriptyline concentration at 25°C was slow. At 
six months 68% of the drug was still present in the blood samples. After twelve 
months of storage more than 50% of the drug could be detected. 
At 5°C blood Amitriptyline was stable even after twelve months of 
storage, 76% of the drug can be detected. 
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Table 30: The Concentration of Amitriptyline (J.lg/ml) in Blood Solution Stored at 5, 25 and 
-"0 D C t' d f D Z 12 h 
-
e rees en Igra e rom ay ero up to mont s. 
Concentration Concentration Concentration 
Storage When Stored When Stored When Stored 
at 2SoC at SoC at -20°C 
Zero Dav 9.5 9.8 10 
1 month 9.7 10 10 
2 months 10 10 10 
3 months 9.2 9.6 8.7 
4 months 10 7.6 8.6 
5 months 7.6 10 10 
6 months 6.8 7.2 8,7 
7 months 5.6 8.0 8.5 
8 months 5.9 8.2 9.2 
9 months 6.0 8.6 9.0 
10 months 6.2 8.3 8.9 
11 months 6.5 7.9 8.5 
12 months 5.5 7.6 8.4 
At 5°C and -20°C up to six months the loss in drug concentration was 
3900 ng/ml and 2900 ng/ml, respectively. The loss in concentration reached up 
to 5400 nglml and 4600 ng/ml from the original concentration at SoC and -
20°C, respectively after one year of storage. 
At -20°C the recoveries of blood Amitriptyline at six months (being half 
the period of storage) was that 87% of the drug could be detected and at twelve 
months 84% of the drug could be detected. 
From day zero up to the fourth month at the storage temperature 25°C 
Amitriptyline there was almost 100% recovery and the fluctuation in the drug 
concentration showed that in the first month 97% of the drug could be detected 
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while in the second month 100% of the drug could be detected. This could be 
due to the drug being bound to blood proteins and released the second month. 
A drop in concentration was noticed after the fourth month. A drop of 
2400 ng/ml in concentration between the fourth and fifth month. The drop in 
concentration reached an average of 2100 ng/ml in concentration at up to the 
twelfth month. At SoC a fluctuation in the drop of concentration was noticed at 
up to the fifth month. At some months a drop was noticed but the following 
month it levelled off to the original concentration. The loss in concentration 
reached 2700 ng/ml at up to one year of storage but drug was more stable than 
at 2S°C. At -20°C the drug was very stable; the loss in drug concentration was 
1600 ng/ml of the original concentration after one year of storage. 
From the above findings blood Amitriptyline is relatively stable at the 
three different temperatures (SOC, 2SoC and -20°C). Even after twelve months of 
storage, the drug can still be detected. 
Amitriptyline concentration after four months of storage at 2SoC is 
shown in Figure 3S. 
A comparison between blood Amitriptyline samples stored at the three 
different temperatures is shown in Figure 36. 
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Figure 35 Chromatogram of Amitriptyline after four months storage at 25°C by Gc. 
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4.4.11.2 Nortriptyline Stability 
The result of blood solution supplied with Nortriptyline stored at the 
three different storage temperatures and analysed in the deSignated time are 
summarised in Table 31. 
Table 31: The Concentration of Nortriptyline <Jlglml) in Blood Solution Stored at 5, 25 and -
20 D C r d fr 0 Z t 12 th eg ees en 19ra e om a erouE 0 mon s. 
Concentration Concentration Concentration 
Storage When Stored When Stored When Stored 
at 2SoC at SoC at -20°C 
Zero Day 9.4 10 9.6 
1 month 6.3 8.7 10 
2 months 5 10 10 
3 months 5.0 8.4 8.7 
4 months 4.7 6.9 7.9 
5 months 4.3 6.5 6.9 
6 months 4.3 6.1 7.1 
7 months 4.0 5.3 6.5 
8 months 3.9 5.3 6.5 
9 months 4.1 5.1 6.1 
10 months 3.5 4.9 5.5 
11 months 3.1 4.9 5.7 
12 months 2.5 4.6 5.4 
At 25°C the blood Nortriptyline showed no stability. After six months 
only 43% of the drug could be recovered and after one year only 25% could be 
detected. 
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From the first month, the drop in concentration was noticed. 3100 ng/ml 
of the drug was lost. Up to the eighth month the loss in concentration reached 
5500 ng/ml and it continued up to a year to reach 6900 ng/ml from the original 
concentration. 
With 5°C and -20°C being more stable, more than 62% of the drug could 
be recovered after six months and after one year 46% and 54% were recovered 
at 5°C and -20°C, respectively. 
Up to six months at 5°C and -20°C, the loss in drug concentration was 
3900 ng/ml and 2900 ng/rnl, respectively. The loss in concentration reached up 
to 5400 ng/ml and 4600 ng/ml from the original concentration at 5°C and 
-20°C, respectively, after one year of storage. 
As a result of this study Nortriptyline was shown to be unstable, being 
most stable for those samples stored at -20°C. A significant decrease in 
Nortriptyline concentration was observed for samples stored at both 25°C and 
5°C temperatures, with the greater and more rapid decrease occurring in the 
blood samples stored at room temperature. 
Figure 37 shows the decline in Nortriptyline concentration for blood 
samples at 5°C, 25°C and -20°C. 
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Figure 38 shows the chromatogram of Nortriptyline after six months of 
storage at SOC 
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4.4.11.3 Imipramine Stability 
Imipramine stability in blood was investigated where 'spiked' samples of 
blood with Imipramine at a concentration of 10 llg/ml from day zero until 
twelve months. 
The results of the blood solution 'spiked' with Imipramine stored at the 
three storage temperatures was analysed at the designated time and are 
presented in Table 32. 
Table 32: The Concentration of Imipramine (J.lglmD in Blood Solution Stored at 5, 25 and -
20 D fro e~Tees Centigrade mDa Zero up to 12 months. 
Concen tra tion Concentration Concentration 
Storage When Stored When Stored When Stored 
at 2SoC at SOC at -20°C 
Zero Day 9.5 9.7 10 
1 month 6.6 10 10 
2 months 4.8 6.7 10 
3 months 3.3 10 8.4 
4 months 9.1 6.6 7.8 
5 months 6.9 7.3 8.4 
6 months 6.6 6.4 7.7 
7 months 5.3 7 8 
8 months 5.1 6.7 7.8 
9 months 4.9 6.4 7.5 
10 months 4.3 6.1 6.9 
11 months 4.6 5.5 7.1 
12 months.4 4.4 5.4 6.9 
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Figure 39 shows Imipramine concentration after nine months of storage 
at-20°e. 
Figure 40 shows the decline in Imipramine concentration from day zero 
up to twelve months when stored at the three different temperatures (5°C, 25°C 
and -20°C). Samples stored at 25°C declined unsteadily. At twelve months only 
44% of the drug could be detected. The samples that were refrigerated showed 
stability up to the seventh month where 70% of the drug could still be recovered 
and even after one year of storage more than 50% of the drug could still be 
recovered. The same is the case for the samples stored at -20°C where 69% of 
the drug could be recovered after one year of storage. 
At 25°C a very fast drop in concentration was noticed for the first three 
months to reach 6200 ng/ml in concentration. A sudden rise in concentration 
was noticed at the fourth month, then the concentration dropped again to reach 
an amount of 5100 ng/ml of the original concentration. The high drop in 
concentration at the start might be due to a high binding of the drug to the 
blood proteins especially at the second and third months. At 5°C and -20°C the 
drop in concentration was not as high as the sample stored at 2S°e. At 5°C the 
loss in concentration reached 4600 ng/ml of the original concentration when 
stored for up to a year while at _20DC the loss in concentration was less; it 
reached 3100 ng/ml after twelve months of storage. 
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Figure 39 Chromatogram of Imipramine after nine months of storage at -20°C by Gc. 
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It is concluded from this study on Imipramine that this drug is relatively 
stable when stored at SOC and -20°C. It could be detected for up to one year at 
any stored temperature. 
4.4.11.4 Chlorpromazine Stability 
Blood samples 'spiked' with Chlorpromazine at a concentration 10 pg/ml 
stored at the three storage temperatures were analysed at designated times. 
The results are tabulated in Table 33. 
Table 33: The Concentration of Chlorpromazine (pgiml) in Blood Solution Stored at 5, 25 
d 20 0 C d fr 0 Z h an - egrees enhgra e om ay ero up to 12 mont s. 
Concentration Concentration Concentration 
Storage When Stored When Slored When Stored 
at 25°C At 5°C at-20°C 
Zero Day 9.1 9.3 9.1 
1 month 10 10 10 
2 months 10 10 10 
3 months 5.5 8.5 10 
4 months 7.6 8.8 9.1 
5 months 4.5 7.9 10 
6 months 4.7 7.5 8.8 
7 months 3.7 7.3 10 
8 months 3.6 6.9 8.7 
9 months 3.4 6.4 8.5 
10 months 2.9 6.7 7.1 
11 months 2.5 5.3 6.9 
12 months 2.5 4.9 6.4 
A steady decrease was noticed for blood Chlorpromazine at the three 
storage conditions. 
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Figure 41 shows Chlorpromazine concentration after twelve months of 
storage at soc. After six months of storage 47% of the drug could be recovered 
and after one year only 2S% could be detected. At SoC and 20°C the drug was 
relatively stable being able to detect 7S% and 88% at SoC and -20°C, 
respectively, after six months of storage and still after one year 64% could be 
detected for the samples stored at -20°C. 
At 25°C the loss in drug concentration was 2400 ng/ml from day zero up 
to the fourth month. After the fourth month the drop in drug concentration 
was very fast and reached a level of loss of 7500 ng/ml of the original 
concentration after one year of storage. The loss in concentration was lower for 
the samples stored at 5°C and -20°C. The loss after ten months was 3300 ng/ml 
for the samples stored at SoC and 2900 ng/ml for the samples stored at -20°C. 
Figure 42 shows the decline in Chlorpromazine concentration in blood 
samples stored at SoC, 25°C and -20°C. 
The conclusion from the Chlorpromazine study is that the best blood 
stability is for the samples stored at -20°C, being followed by those stored at 
50°C and the least stable being the samples stored at room temperature. 
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Figure 41 Chromatogram of Chlorpromazine after twelve months of storage at SOC by Gc. 
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4.4.12 TESTING FOR BREAKDOWN PRODUCT OF TeA THROUGH GC-MS SYSTEM 
Samples taken at different times and temperatures for the four drugs 
(Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine) were tested 
after they had been tested for its change in concentration and tested for any 
breakdown products of its drugs. Figure 43 shows the mass spectrum of 
Amitriptyline at 25°C after seven months of storage. The peaks obtained are 
the principal peaks at m/z:58, 59, 202, 42. No unknown peaks were obtained. 
Figure 44 shows the mass spectrum of Imipramine at -20°C after nine 
months of storage. The peaks obtained again are the principal peaks at m/z:58, 
235,85,234,236,195,193. No unknown peaks were obtained. 
This shows that none of the samples had any breakdown products when 
analysed through GC-MS. 
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CHAPTERS 
CONCLUSION 
This study was primarily concerned with the stability of drugs in post-
mortem blood and was constructed for different periods of time under three 
different storage conditions. Differences in stability was noticed for different 
drugs due to the difference in chemical structures. The main aim of this study 
was to estimate the time of persistence of the drugs in post-mortem blood 
before they ceased to be recognised by initial screening and assay procedures. 
In this work the stability of some commonly encountered benzodiazepines and 
tricyclic antidepressants was investigated for one year of storage at three 
different temperatures (5°C, 25°C and -20°C). Diazepam was found to be 
relatively stable over a period of one year with more than 50% recovered 
regardless of the storage temperature. Desmethyldiazepam, Temazepam and 
Triazolam were stable being able to be detected at up to a year when stored at 
any temperature. 
Amitriptyline, Nortriptyline, Imipramine and Chlorpromazine were also 
found to be stable under the storage conditions studied, with a steady decline in 
their concentration with time at up to a year. 50% of the drugs Amitriptyline 
and Imipramine were recovered regardless of the storage temperature. 
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Nortriptyline and Chlorpromazine could be detected up to a year when stored 
at any temperature. 
The study showed that at therapeutic and toxic concentrations of the 
studied drugs, a reasonable amount of the drugs were still detectable after one 
year of storage, regardless of the temperature. This finding provides significant 
information for the forensic toxicologist to assist with the interpretation of 
results even in one year old samples. 
To undertake the study, published methods for the analysis of the drugs 
In biological matrices were investigated. An optimised procedure for the 
determination of benzodiazepine drugs by reversed-phase high pressure liquid 
chromatography was developed. It required an initial extraction of the drugs 
using a solid phase extraction based on a C8 bonded phase sorbent. Tricyclic 
antidepressants were determined by gas chromatography with FID/NPD 
detectors following an extraction method based on liquid-liquid extraction. 
This combination was demonstrated to be the most effective procedure to 
analyse for these drugs and Chlorpromazine in blood samples. 
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